Download Peer Reviewed Original Articles Published July 1, 2001

Original Articles Published July 1, 2001 - June 30, 2004
Abed, Y., Coulthart, M., Li, Y., and Boivin G. (2003). Evolution of surface and internal genes of
influenza B viruses isolated in the province of Quebec, Canada, during the 1998-2001 period. Virus
Genes. 27(2): 125-135.
Abed, Y., Hardy, I., Li, Y., and Boivin, G. (2002). Divergent evolution of hemaggultinin and
neruminidase genes in recent influenza A: H3N2 viruses isolated in Canada. (2002). J. Med. Virol. 67:589595.
Abeku T.A. et al (Nagelkerke NJD). Effects of meteorological factors on epidemic malaria in Ethiopia: a
statistical modelling approach based on theoretical reasoning. Parasitology 2004; 128: 585-93.
Abraham E, Reinhart K, Opal S, Demeyer I, Doig C, Rodriguez AL, Beale R, Svoboda P, Laterre PF, Simon
S, Light B et al. Efficacy and safety of tifacogin (Recombinant tissue factor pathway inhibitor) in severe
sepsis. A randomized controlled trial. JAMA 290:238-47, 2003.
Alberto Severini A., Sevenhuysen C., Michael Garbutt M., and Tipples G. (2003) Structure of
replicating intermediates of human herpesvirus type 6. Virology 314:443-450.
Alfa M, Robson D, Davi M, Bernard K, VanCaeseele P, Harding GKM. An Outbreak of Necrotizing
Enterocolitis Associated with a Novel Clostridium Species in a Neonatal Intensive Care Unit. Clin Infect
Dis. 2002:35(Suppl 1);S101-S105.
Alfa MJ, A. Ilynyckyj, M MacFarlane, V Preece, S Allford, B Fachnie. Microbial overgrowth in water
perfusion esophageal/rectal motility. Endoscopy 2002;55:209-13.
Alfa MJ, Castillo J. Impact of FDA policy change on the reuse of single-use medical devices in Michigan
hospitals. Am J Infect Contr 2004Oct;32(6):337-41.
Alfa MJ, Jackson, M. A new hydrogen peroxide-based medical device detergent with germicidal
properties: Comparison with enzymatic cleaners. AJIC 2001, 29:1-10.
Alfa MJ, N Olson, P DeGagne, M Jackson. Evaluation of rapid readout biological indicators for 132oC
gravity and 132 vacuum-assisted steam sterilization cycles using a new automated fluorescent reader.
Infect Control Hosp Epidemiol 2002.
Alfa MJ, N Olson, P DeGagne, M Jackson. Survey of reprocessing methods, residual viable bioburden
and soil levels in patient-ready ERCP scopes used in Canadian centers. Infect Control Hosp Epidemiol
2002;23:198-206.
Alfa MJ, Nemes R. Inadequacy of manual cleaning for reprocessing single-use, triple-lumen
sphinctertomes: simulated-use testing comparing manual with automated cleaning methods. AJIC
2003;31:193-207.
Alfa MJ, Nemes R. Manual versus automated methods for cleaning reusable accessory devices used in
minimally invasive surgical procedures. J Hosp Infect 2004Sep;58(1):50-8.
Alfa MJ, Swan B, VanDekerkhove, Pang P, Harding GKM. The diagnosis of Clostridium difficileassociated diarrhea: comparison of Triage C. difficile panel, EIA for Tox A/B and cytotoxin assays.
Diagn Microbiol and Infect Dis. 2002:43;257-263.
Alimonti JB, Ball TB and Fowke KR. Mechanisms of CD4+ T Lymphocyte Cell Death in HIV/AIDS. J. Gen
Virol. 2003; 84: 1649-1661 and JGV Direct on-line publication.
Alley E.S. et al (Nagelkerke NJD). The uptake of Onchocerca volvulus (nematoda: onchocercidae) by
simulium (Diptera: simuliidae) is not strongly dependent on the density of skin microfilariae in the human
host. J. Medical Entomology. J Med Entomol. 2004 Jan;41(1):83-94.
Alley, E.S. et al (Nagelkerke NJD). Macrofilaricides and Onchocerciasis Control, Mathematical Modelling
of the Prospects for Elimination' BioMedCentral Public Health, 2001: 1-12.
Aoki FY, Macleod MD, Paggiaro P et al. and the IMPACT Study Group (P. Orr, member). Early
administration of oral oseltamivir increases the benefits of influenza treatment. Journal of Antimicrobial
Chemotherapy 2003;51:123-9.
Aoki FY. Management of genital herpes in HIV-infected patients. Herpes 2001; 8:41-45 (invited paper).
Aoki, FY. Contemporary antiviral drug regimens for the prevention and treatment of orolabial and
anogenital Herpes simplex virus infection in the normal host: four approved indications and 13 off-label
uses. Can J Infect Dis (invited paper) 2003; 14:17-27.
Aral SO, Blanchard JF. Phase-specific approaches to the epidemiology and prevention of sexually
transmitted diseases: an overview. Sex Transm Infect 2002;78 Suppl 1:i1-2.
Araya T. et al (Nagelkerke NJD). Lay diagnosis of causes of death for monitoring AIDS mortality in
Addis Ababa, Ethiopia. Trop Med Int Health. 2004 Jan;9(1):178-86
Ariano RE, Franczuk C, Fine A, Harding GKM, Zelenitsky SA. Challenging the current treatment
paradigm for methicillin-resistant Staphylococcus epidermidis peritonitis. Perit Dial Int. 2002;22(3):3358.
Artsob H, Lindsay R, Drebot M. 2003. Laboratory based surveillance for West Nile virus activity in
Canada. Canadian Journal of Medical Laboratory Science 65:86-89.
Austin RJ, Whiting TL, Anderson RA, Drebot MA. (2004). An outbreak of West Nile virus-associated
disease in domestic geese (Anser anser domesticus) upon initial introduction to a geographic region, with
evidence of bird to bird transmission. Can Vet J. 45(2):117-23.
Babiuk, S., Skowronski, D.M., De Serres, G., HayGlass, K.T., Brunham, R.C., Babiuk, L. Aggregate
content influences the type 1:type 2 immune response to influenza vaccine: evidence from a mouse
model. J. Med. Virol. 72(1):138-42. 2004.
Bai H, J. Yang, H. Qiu, S. Wang, Y. Fan and X. Yang. Expression of proinflammatory cytokines following
chlamydia trachomatis lung infection. Immunol. J. 8:119-124, 2004.
Bai H, J. Yang, H. Qiu, S. Wang, Y. Fan and X. Yang. Production of MIP-1 and MCP chemotactic
cytokines following Chlamydia trachomatis lung infection and its relationship with host immune defence.
Chin. J. Immunol. 23:110-114 2004.
Bailey RC, Plummer FA, Moses S. Male circumcision and HIV prevention: Current knowledge and
future research directions. Lancet Infectious Diseases 2001;1:223-31.
Ball TB, Plummer FA, HayGlass KT. Improved mRNA quantitation in light cycler RT-PCR. Int Arch
Allerg Immunol 2003;130(1):82-6.
Bandak SI, Turnak MR, Allen BS, Bolzon LD, Preston DA, Bouchillon SK, Hoban DJ. Antibiotic
susceptibilities among recent clinical isolates of Haemophilus influenzae and Moraxella catarrhalis from
fifteen countries. European Journal of Infectious Diseases, 2001;20:55-60.
Barrett John W., Jing-Xin Cao, Sheela Hota-Mitchell and Grant McFadden. Viral Subversion of Immune
Responses: Immunomodulatory Proteins of Myxoma Virus. Seminar in Immunology 2001, 13(1): 73-84
Bastien N, Liu L, Ward D, Taylor T, and Li Y. (2004).Genetic variability of the G glycoprotein gene of
Human Metapneumovirus. J. Clin. Microbiol. 42: 3532-3537.
Bastien, N, Ward, D, Van Caeseele, P, Brandt, K, Lee, S, McNabb, G, Klisko, B, Chan, E, and Li, Y.
(2003). Human metapneumovirus infection in the Canadian population. J. Clin. Microbiol. 41:4642-4646.
Bastien, N., Normand, S., Brown, T., Ward, D., Peret, T., Boivin, G., Anderson, L., and Li, Y. (2003).
Sequence analysis of the N, P, M, and F genes of Canadian human metapneumovirus strains. Virus
Research. 93: 51-62.
Baucheron S, S Tyler, D Boyd, MR Mulvey, E. Chaslus-Dancla, A. Cloeckaert . 2004. AcrAB-TolC directs
efflux-mediated multidrug resistance in Salmonella enterica serovar typhimurium DT104 Antimicrob
Agents Chemother. 48:3729-35.
Beattie T, Kaul R, Rostron T, Dong T, Easterbrook P, Jaoko W, Kimani J, Plummer F, McMichael A,
Rowland-Jones S. Screening for HIV-specific T-cell responses using overlapping 15-mer peptide pools or
optimized epitopes. AIDS 2004;18:1-12.
Becker M, Grant HJ, Nichoil KA, Zhanel G, Orr PH, Hoban DJ. Metastatic infection with
fluoroquinolone-resistant Streptococcus pneumoniae following levofloxacin treatment of fluoroquinolonesusceptible S. pneumoniae (letter). Can J Infect Dis 2003;14(5):291.
Becker, M. L., A. A. Suchak, J. N. Wolfe, R. Zarychanski, A. Kabani, and L. E. Nicolle. 2003.
Mycobacterium neoaurum bacteremia in a hemodialysis patient. Can. J. Infect. Dis. 14(1):45-48.
Becker, M.M., Goral, M.I., Hazelton, P.R., Baer, G.S., Rodgers, S.E., Brown, E.G., Coombs, K.M., and
T.S. Dermody. (2001). Reovirus sigmaNS protein localizes to viral inclusions and is required for viral
assembly. J. Virol. 75:1459-1475. [Cover illustration, subsequent month’s cover]
Belland, R.J., Scidmore, M., Crane, D., Hogan, J., Carlson, J., Whitmire, B., McClarty, G. and Caldwell, H.D.
2001. Chlamydia trachomatis cytotoxicity associated with complete and partial cytotoxin genes. Proc Natl
Acad Sci U S A. 98:13984-9.
Bernard, K., C. Munro, D. Wiebe and E. Ongsansoy. 2002. Characteristics of rare or recently-described
Corynebacterium species recovered from human clinical material in Canada. J. Clin. Microbiol. 40: 43754381
Bernard, K., L. Shuttleworth, C. Munro, J. C. Forbes-Faulkner, D. Pitt, J. H. Norton, A. D. Thomas. 2002.
Propionibacterium australiense sp. nov. derived from granulomatous bovine lesions Anaerobe 8: 41-47
Bernard, K., L. Shuttleworth, C. Munro, J. C. Forbes-Faulkner, D. Pitt, J. H. Norton, A. D. Thomas. 2002.
Propionibacterium australiense - publication as valid bacterial name, validation list 88. 2002. Int. J.
System. Evol. Micobiol. 52:1915.
Bernstein CN, Blanchard JF, Metge C, Yogendran M. Does the use of 5-aminosalicylates in inflammatory
bowel disease prevent the development of colorectal cancer? Am J Gastroenterol 2003;98:2784-8.
Bernstein CN, Blanchard JF, Metge C, Yogendran M. The association between corticosteroid use and
development of fractures among IBD patients in a population-based database. Am J Gastroenterol
2003;98:1797-801.
Bernstein CN, Kraut A, Blanchard JF, Rawsthorne P, Yu N, Walld R. The relationship between
inflammatory bowel disease and socioeconomic variables – an examination of employment, income,
disability, education and marital status in IBD. Am J Gastroenterol 2001;96(7):2117-25.
Bernstein CN, Orr K, Blanchard JF, Sargent M, Workman D. The development of an assay for antibodies
to Saccharomyces cerevisiae: Easy, cheap and specific for Crohn's disease. Can J Gastroenterol
2001;15:499-504.
Berry JD, Jones S, Drebot M, Andonov A, Sabara M, Yang XY, Weingartl H., Fernando, Marszhall P,
Gren J, Nicolas B, Andanov M, Ranada F, Gubbins M, Ball B, Kiching P, Li Y, Kabani A, and Plummer F.
Development and immunochemical characterization of neutralizing monoclonal antibodies to the SARScoronavirus (hCoV). J. Virol Methods, 120 (1): 87-96
Berry JD, Rutherford J, Silverman GJ, Kaul R, Elia M, Gobuty S, Fuller R, Plummer FA, Barbas III, CF.
Development of functional human monoclonal single-chain variable fragment antibody against HIV-1 from
human cervical B Cells. Hybridoma Hybridomics 2003;22(2):97-108.
Berry, J.D. , Licea, A., Popkov, M., Cortez, X., Fuller, R., Elia, M., Kerwin, L., and C.F. Barbas III.
(2003) Rapid monoclonal antibody generation via dendritic cell targeting in vivo. Hybridoma and
Hybridomics 22 (1), 23-31.
Bertelsen MF, Olberg RA, Crawshaw GJ, Dibernardo A, Lindsay LR, Drebot M, Barker IK. (2004). West
Nile virus infections in the eastern loggerhead shrike (Lanius ludovicianus migrans): pathology,
epidemiology, and immunization. J Wildl Dis 40: 538-42.
Best JM, S O’Shea, G Tipples, N Davies, S Al-Khusaiby, A Krause, L Hesketh, L Jin, G Enders.
Interpretation of rubella serology in pregnancy - pitfalls and problems. BMJ 325:147-8 (2002).
Best LM, Haldane DJM, Keelan M, Taylor DE, Thomson ABR, Loo V, Fallone CA, Lyn P, Smaill FM, Hunt,
Gaudreau C, Kennedy J, Alfa M, Pelletier R, Veldhuyzen van Zanten SJO. Multilaboratory Comparison of
Proficiencies in Susceptibility Testing of Helicobacter pylori and Correlation between Agar Dilution and E
test Methods. Antimicro Agents Chemother. 2003;47(10):3138-3144.
Bilenki L, Y. Fan, J. Yang, S. Wang and X. Yang. Natural killer T (NKT) cells contribute to airway
eosinophilic inflammation induced by ragweed through enhanced IL-4 and eotaxin production. Eur J
Immunol, 34:345-354, 2004
Bilenki L, Y. Fan, S. Wang, J. Yang, X. Han, X. Yang. Chlamydia trachomatis infection inhibit asthma-like
reaction induced by ragweed. Clin. Immunol.102:28-36, 2002.
Bird TG, Kaul R, Rostron T, Kimani J, Embree J, Dunn PPJ, Bwayo JJ, Plummer FA, Rowland-Jones SL,
the Oxford-Nairobi HLA Collaborative Group, Dong T. HLA typing in a Kenyan cohort identifies novel
class I alleles alleles that restrict cytotoxic T-cell responses to local HIV-1 clades. AIDS 2002;16:18991904.
Birmingham, N., Payankaulam, S., Thanesvorakul, S., Stefura, B., HayGlass K., and Gangur V. An
ELISA-based method for measurement of food-specific IgE antibody in mouse serum: an alternative to
the passive cutaneous anaphylaxis assay. J. Immunol. Methods. 275:89-98. 2003.
Bjerregaard P, Orr P. “John Arthur Hildes Circumpolar Health Awards” (Editorial). Int J Circ Hlth 2003;62:34.
Bjornson GL, Scheifele DW, Halperin SA and Members of the Canadian Paediatric Society / health Canada
Immunization Monitoring Program, Active (IMPACT). Population-based epidemiology of invasive
pneumococcal infection in children in nine urban centers in Canada, 1994 through 1998.(B. Law, IMPACT
Winnipeg site investigator) Pediatric Infectious Disease Journal, 2002; 21:947-950.
Blackwood K, Al-Azem A, Elliot L, Hershfield E and A Kabani. 2003. Conventional and Molecular
Epidemiology of Tuberculosis in Manitoba. BMC Infect. Dis. 3: 18.
Blackwood, K., C. Y. Turenne, D. Harmsen, and A. M. Kabani. 2004. Reassessment of Sequence-based
Targets for Identification of Bacillus species. J. Clin Microbiol 42:1626-30.
Blanchard JF, Bernstein CN, Wajda A, Rawsthorne P. Small-area variations and socio-demographic
correlates for the incidence of Crohn’s disease and ulcerative colitis. Am J Epidemiol 2001;154:328-35.
Blanchard JF. Populations, pathogens and epidemic phases: closing the gap between theory and
practice in the prevention of sexually transmitted diseases. Sex Transm Infect 2002;78 Suppl 1:i83-88.
Blondeau JM, Vaughan D, Laskowski R, Borsos S, The Canadian Antimicrobial Study Group (D Hoban,
member). Susceptibility of Canadian isolates of Haemophilus influenzae, Moraxella catarrhalis and
Streptococcus pneumoniae to oral antimicrobial agents. International Journal of Antimicrobial Agents,
2001;17:457-464.
Boatin BA et al (Nagelkerke NJD). Detection of Onchocerca volvulus infection in low prevalence areas:
a comparison of 3 diagnostic Methods. Parasitology. 2002 Dec;125(Pt 6):545-52.
Bock GW, Embil JM. The Diabetic Foot: Imaging Considerations. COA Bulletin 2002; 58: 19-22.
Boogaerts M., Winston D.J., Bow E.J., Garber G., Reboli A.C., Schwarer A.P., Novitzky N., Boehme A.,
Chwetzoff E., De Beule K., and the Itraconazole Neutropenia Study Group: Intravenous and Oral
Itraconazole versus Intravenous Amphotericin B Deoxycholate as Empirical Antifungal Therapy for
Persistent Fever in Neutropenic Patients with Cancer Who Are Receiving Broad-Spectrum Antibacterial
Therapy. Ann Intern Med, 2001; 135(6): 412-422.
Booth S, Drebot MA, Martin IE, Ng LK. (2003) Design of oligonucleotide arrays to detect point
mutations: Molecular typing of antibiotic resistant strains of Neisseria gonnorrhoeae and hantavirus
infected deer mice. Mol Cell Probes 17: 77-84.
Borgdorff MW et al (Nagelkerke NJD). Transmission of Mycobacterium tuberculosis depending on the
age and sex of source cases. Am. J. Epid. 2001 Nov 15;154(10):934-43.
Borsboom GJ. et al (Nagelkerke NJD). Impact of ivermectin on onchocerciasis transmission: assessing
the empirical evidence that repeated ivermectin mass treatments may lead to elimination/eradication in
West-Africa. Filaria J. 2003 Mar 24;2(1):8.
Bouchillon SK, Hoban DJ, Johnson JL, Johnson BM, Butler DL, Saunders KA, Miller LA, Poupard JA. In
vitro activity of gemifloxacin and contemporary oral antimicrobial agents against 27,247 gram-positive
and gram-negative aerobic isolates: a global surveillance study. International Journal of Antimicrobial
Agents, 2004;23:181-196.
Bouchillon SK, Johnson BM, Hoban DJ, Johnson JL, Dowzicky MJ, Wu DH, Visalli MA, Bradford PA.
Determining incidence of extended spectrum ß-lactamase producing Enterobacteriaceae, vancomycinresistant Enterococcus faecium and methicillin-resistant Staphylococcus aureus in 38 centres from 17
countries: the PEARLS study 2001-2002. International Journal of Antimicrobial Agents, 2004;24:119-124.
Bouwknegt M et al (Nagelkerke NJD). Risk factors for the presence of Campylobacter spp. in Dutch
broiler flocks. Prev Vet Med. 2004 Jan 30;62(1):35-49.
Bow E.J., Laverdière M., Lussier N., Rotstein C., Cheang M.S., Ioannou S.: Antifungal Prophylaxis for
Severely Neutropenic Chemotherapy Recipients: A Meta-Analysis of Randomized Controlled Clinical
Trials. Cancer 2002; 94(12):3230-3246.
Bow, E.J. Fluoroquinolone-Based Antibacterial Chemoprophylaxis in Neutropenic Cancer Patients Works
for Defined Outcomes in Defined Populations, but Must Be Used Wisely. JNCCN 2004: 2(5) 433-444.
Bowles, S., Lee, W., Simor, A. E, Vearncombe, M., Leob, M., Tamblyn, S., Fearon, M., Li, Y., and McGeer,
A. (2002). Use of oseltamivir during influenza outbreaks in Ontario nursing home, 1999-2000. J. Am
Geriatr Soc. 50: 608-616.
Boyd D., A. Cloeckaert, E. Chaslus-Dancla, and M. R. Mulvey. 2002. Characterization of Variant
Salmonella Genomic Island 1 Multidrug Resistance Regions from Serovars Typhimurium DT104 and
Agona. Antimicrobial Agents and Chemotherapy. 46:1714-1722.
Boyd D., G. Peters, A. Cloeckaert, K. Boumedine, E. Chaslus-Dancla, H. Imberechts, and M. Mulvey.
2001. Complete nucleotide sequence of a 43 kb genomic island associated with the multidrug resistance
region of Salmonella enterica Typhimurium DT104 and its identification in phage type DT120 and serovar
Agona. Journal of Bacteriology. 183:5725-5732.
Boyd, D., P. Kibsey, D. Roscoe, M. R. Mulvey and the Canadian Nosocomial Infection Surveillance
Program (CNISP). 2004. Enterococcus faecium N03-0072 carries a new VanD-type vancomycin
resistance; characterization of the vanD5 operon. Journal of Antimicrobial Chemotherapy. 54:680-683.
Boyd, D., T. Cabral, P. Van Caeseele, J. L. Wylie, and M.R. Mulvey. 2002. Molecular
characterization of the vanE gene cluster in vancomycin-resistant Enterococcus faecalis N00-410 isolated
in Canada. Antimicrob. Agents Chemother. 46:1977-1979.
Bras APM, Sitar DS, Aoki FY. Comparative bioavailability of acyclovir from oral valaciclovir and acyclovir
in patients treated for recurrent genital herpes simplex virus infection. Can J Clin Pharmacol 2001;
8(4):207-211.
Brisson M, Edmunds WJ, Law B, Gay NJ, Walld R, Brownell M, Roos L, De Serres G. Epidemiology of
varicella zoster virus infection in Canada and the United Kingdom. Epidemiology Infect, 2001; 127:305314.
Broliden K, Hinkula J, Devito C. Kiama P, Kimani J, Trabbatoni D, Bwayo JJ, Clerici M, Plummer F, Kaul
R. Functional HIV-1 specific IgA antibodies in HIV-1 exposed, persistently IgG seronegative female sex
workers. Immunol Lett 2001;79:29-36.
Buchholz U et al (Nagelkerke NJD). An outbreak of foodborne illness associated methomyl
contaminated salt. JAMA, 2002. 604-610.
Bulloch B, Kabani A, Tenenbein M. 2003. Oral dexamethasone for the treatment of pain in children with
acute pharyngitis: A randomized, double-blind, placebo-controlled trial. Ann Emerg Med. 41(5):601-608.
Burdz, T. V., J. Wolfe and A. Kabani. 2003. Evaluation of sputum decontamination methods for
Mycobacterium tuberculosis using viable colony counts and flow cytometry. Diagn Microbiol Infect
Disease.47:503-509.
Buxton, J.A., Skowronski D.M., Ng, H., Marion, S., Li, Y., King, A., and Hockin, L. (2001). Influenza revaccination of elderly travellers; antibody response to single influenza vaccination and revaccination at 12
weeks. J. Infect. Dis. 184 (2):188-191.
Byrne C, Doherty D, Mooney A, Byrne M, Woodward D, Johnson W, Rodgers F, Bourke B. Basis of the
superiority of cefoperazone amphotericin teicoplanin for isolating Campylobacter upsaliensis from stools.
J Clin Microbiol. 2001 Jul;39(7):2713-6.
Cabral, T., A. Jolly, and J. L. Wylie. 2002. Genotypic diversity of Chlamydia trachomatis and
concordance with sexual network data. J. Infect. Diseases. 187: 279-286.
Caldwell HD, Wood H, Crane D, Bailey R, Jones RB, Mabey D, Maclean I, Mohammed Z, Peeling R,
Roshick C, Suchland RJ, Stamm WE, Taylor L, West SK, Quinn TC, Belland RJ, McClarty G.
Polymorphisms in Chlamydia trachomatis tryptophan synthase genes differentiates between genital and
ocular isolates: Implications in pathogenesis and infection tropism. J. Clin. Invest. 111:1757-69, 2003.
Calisher CH, Blair CD, Bowen MD, Casals J, Drebot MA, Henchal EA, Karabatsos N, LeDuc JW, Repik PM,
Roehrig JT, Schmaljohn CS, Shope RE, Tesh RB, Weaver SC. (2001). Identification of arboviruses and
certain rodent-borne viruses: Reevaluation of the paradigm. Emerg Infect Dis 7: 756-758.
Campbell, J.D., Stinson, M.J., Simons, F.E.R, Rector, E.S. and HayGlass, K.T. Chemokine receptor
expression and plasma chemokine levels are longitudinally stable in healthy subjects but differences
among subjects are dependent on the mode of receptor quantification. Human Immunology. 62:668-678.
2001.
Campbell, J.D., Gangur, V., Simons, F.E.R. and HayGlass, K.T. Allergic humans are hypo-responsive to a
CXCR3 ligand-mediated type 1 immunity promoting loop. FASEB J. 2004 Feb;18(2):329-31
Campbell, J.D., Stinson, M.J., Simons, F.E.R., and HayGlass, K.T. Systemic chemokine and chemokine
receptor responses are divergent in allergic versus non-allergic humans. Int. Immunol. 14:1255-63. 2002.
Canosa T, Cohen M, Embil JM. Osteomyelitis of the Maxilla caused by Methicillin Resistant Staphylococcus
aureus. J Oral Maxillofac Surg 2003 61; 387-390.
Cao Jingxin and Grant McFadden. Characterization of the Myxoma Virus M118L protein: a Novel
Essential Poxvirus IMV-Associated Protein. Virus Genes 2001, 23(3): 303-313
Cao Jingxin and Grant McFadden. Manipulation of the Immune System by Virus: Myxoma Virus Model.
Modern Aspects of Immunobiology 2001, 1(5): 179-181.
Cao Jingxin, Melissa L. T. Teoh, Mijin Moon, Grant McFadden and David H. Evans. Leporipoxvirus CuZn Superoxide Dismutase Homologs Inhibit Cellular Superoxide Dismutase, but are not Essential for Virus
Replication or Virulence. Virology 2002, 296(1):125-135
Carrie AC, Metge C, Collins D, Harding GKM and Zhanel GG. Use of administrative healthcare claims to
examine the effectiveness of trimethoprim-sulfamethoxazole versus fluoroquinolones in the Treatment of
community-acquired pyelonephritis. Journal of Antimicrobial Chemotherapy 2004;53:512-517.
Carrie AC, Metge C, Collins DM, Harding GKM and Zhanel GG. Predictors of receipt of a
fluoroquinolone versus trimethoprim-sulfamethoxazole for treatment of acute pyelonephritis in women in
Manitoba Canada. Pharmacoepidemiology and Drug Safety 2004;Feb10:22-33.
Charrel R., Lemasson JJ, Garbutt M, Khelifa R, Mico PD, Feldmann H, Lamballerie X (2003). New insight
into the evolutionary relationship between arenaviruses provided by comparative analysis of small and
large segment sequence. Virology 317: 191-196.
Charrel RN, Feldmann H, Fulhorst CF, Khelifa R, de Chesse R, de Lamballerie X. (2002). Phylogeny of
New World arenaviruses based on the complete coding sequences of the small genomic segment
idnetified an evolutionary lineage produced by intrasegmental reocmbination. Biochem. Biophys. Res.
Commun. 296: 1118-1124.
Cheng ZQ, Bose D, Jacobs H, Light RB, Mink SN. Sepsis causes presynaptic histamine H3 and alpha-2adrenergic dysfunction in canine myocardium. Cardiovasc Res 56:225-34, 2002.
Cherneski CL, Embil JM. Necrotizing Fascitis. Saudi Med J 2001; 22: 565-568.
Chougnet C, Jankelevich, S, Fowke KR, Liewehr DJ, Steinberg SM, Mueller BU, Pizzo PA, Yarchoan R,
and Shearer GM. Long-term protease inhibitor containing-therapy results in limited improvement in T-cell
function but not restoration of interleukin-12 production in pediatric AIDS patients. J Infect Dis. 2001,
184:201-5.
Chrusch C, Bautista E, Jacobs HK, Light RB, Bose D, Duke K, Mink SN. Blood pH level modulates organ
metabolism of lactate in septic shock in dogs. J Crit Care 17:188-202. 2002.
Clark C, Cunningham J, Ahmed R, Woodward D, Fonseca K, Isaacs S, Ellis A, Anand C, Ziebell K, Muckle
A, Sockett P, Rodgers F. 2001. Characterization of Salmonella associated with pig ear dog treats in
Canada. J Clin Microbiol 39:3962-3968.
Clark CG, Johnson ST, Easy RD, Campbell JL, Rodgers FG. 2002. PCR for the detection of cdt-III and
the relative frequencies of cytolethal distending toxin variant-producing Escherichia coli from Humans and
Cattle. J Clin Microbiol 40:2671-2674.
Clark CG, Kruk TMAC, Bryden L, Hirvi Y, Ahmed R, Rodgers FG. 2003. Subtyping of Salmonella enterica
serotype Enteritidis strains by manual and automated Pst I-Sph I ribotyping. J Clin Microbiol 41:27-33.
Clark CG, Price L, Ahmed R, Woodward DL, Melito PL, Rodgers FG, Jamieson F, Ciebin B, Li A, Ellis A.
2003. Characterization of waterborne outbreak-associated Campylobacter jejuni, Walkerton, Ontario.
Emerg Infect Dis 9:1232-1241.
COMMITTEE FOR CANADIAN PAEDIATRIC AIDS RESEARCH GROUP (J Embree, CHAIR). Paediatric
Infectious Disease Notes. Nevirapine use to reduce mother-to-child transmission of HIV in Canada. Can J
Infect Dis 12:13-14, 2001 & Paediatrics and Child Health 6:121-122, 2001.
Conly, J., M. Ofner-Agostini, S. Paton, L. Johnston, M. Mulvey, A. Kureishi, L. Nicolle, A. Matlow, The
Canadian Epidimiology Committee, and The Canadian Nosocomial Infection Surveillance Program. 2001.
The emerging epidemiology of vancomycin-resistance in Canada: Results of the Canadian Nosocomial
Infection Surveillance Program Passive Reproting Network 1994-1998. The Canadian Journal of Infection
Control. 16:71-80.
Conly, J.M., Ofner-Agostini, M., Paton, S., Johnston, L., Mulvey, M., Kureishi, A., Nicolle, L., Matlow,
A., the Canadian Hospital Epidemiology Committee and the Canadian Nosocomial Infection Surveillance
Program. The emerging epidemiology of VRE in Canada: Results of the CNISP passive reporting
network, 1994 to 1998. Can Jour Infect Dis 2001; 12:364-370.
Cook, V. J., C. Y. Turenne, J. Wolfe, R. Pauls, and A. Kabani. 2003. Conventional Methods versus 16S
Ribosomal DNA Sequencing for Identification of Nontuberculous Mycobacteria: Cost Analysis. J. Clin.
Microbiol. 41(3): 1010-1015.
Cooper CL, Dyck B, Nicoll D, Olekson K, McLeod J, Nicolle LE, Embil JM. Bed Utilization in Inpatient Care
of Patients with Methicillin-resistant Staphylococcus aureus (MRSA) in a Canadian Tertiary Care Centre. Infect
Control Hosp Epidemiol 2002; 23: 483-484.
Cornu TI, Feldmann H, de la Torre JC (2004). Cells expressing the RING finger Z protein are resistant
to arenavirus infection. J. Viorl. 78: 2079-2983.
Cowan FM, Langhaug LF, Mashungupa GP, Nyamurera T, Hargrove J, Jaffar S, Peeling RW, Brown DW,
Power R, Johnson AM, Stephenson JM, Bassett MT, Hayes RJ. School based HIV prevention in Zimbabwe:
Feasibility and acceptability of evaluation trials using biological outcome measures. AIDS 16:1673-78,
2002.
Crampton T, Light RB, Berg GM, Meyers MP, Schroeder GC, Hershfield ES, Embil JM. Epidemiology and
Clinical Spectrum of Blastomycosis Diagnosis at Manitoba Hospitals. Clin Infect Dis 2002; 34: 1310-1316.
Dalal S, Nicolle L, Zhang L, Marrs C, Harding G, Foxman B. Long term Escherichia coli asymptomatic
bacteriuria in 50 diabetic women. Ann Epidemiol. 2003 Sep;13(8):582-3.
Daneshvar M.I., R. S. Weyant, A. G. Steigerwalt, A. M. Whitney, D.G. Hollis M. P. Douglas, J. P.
Macgregor, J. G. Jordan, L. W. Mayer, S. Rassouli, W. Barchet, Cindy Munro, L. Shuttleworth, and K.
Bernard. 2003. Paracoccus yeeii sp. nov. (Formerly CDC Group EO-2): An Unclassified Bacterial Species
Associated with Human Infection. J. Clin Microbiol 41:1289-1294
Dankers MK et al (Nagelkerke NJD). The HLA-DR phenotype of the responder is predictive of humoral
response against HLA class I antigens. Hum Immunol. 2004. 65: 13-9.
Dawson KG, Gomes D, Gerstein H, Blanchard JF, Kahler KH. The economic cost of diabetes in Canada,
1998. Diabetes Care 2002;25:1303-7.
de Vlas SJ et al (Nagelkerke NJD). Mother-to-child HIV transmission and ARVs. Science. 2002 Dec
13;298(5601):2129.
de Vlas SJ, Nagelkerke NJD, Jha P, Plummer FA. Ensuring effective prevention of mother-to-child
HIV transmission in the era of large-scale antiretroviral therapy. Mother-to-child HIV transmission and
ARVs. Science. 2002;298:2129.
De Wals P, Petit G, Erickson LJ, Guay M, Tam T, Law B, Framarin A. Benefits and costs of immunization
of children with pneumococcal conjugate vaccine in Canada. Vaccine 2003; 21:3757-3764.
Demczuk W, Soule G, Clark C, Ackermann H-W, Easy R, Khakhria R, Rodgers F, Ahmed R. Phage-based
typing scheme for Salmonella enterica Serovar Heidelberg, a causative agent of food poisonings in
Canada. J Clin Microbiol 41:4279-4284.
DeMiranda JR, Drebot M, Tyler S, Shen M, Cameron CE. (2004). Complete nucleotide sequence of
Kashmir bee virus and comparison with acute bee paralysis virus. J Gen Virol. 85(Pt 8):2263-70.
Detich N, Hamm S, Just G, Knox JD, Szyf M: The methyl donor S-adenosylmethionine inhibits active
demethylation of DNA; a candidate novel mechanism for the pharmacological effects of Sadenosylmethionine. J Biol Chem. 278(23):20812-20. 2003.
Devito C, Hinkula J, Kaul R, Kimani J, Kiama P, Lopalco L, Barass C, Piconi S, Trabattoni D, Bwayo JJ,
Plummer F, Clerici M, Broliden K. Cross-clade HIV-1-specific neutralizing IgA in mucosal and systemic
compartments of HIV-1-exposed, persistently seronegative subjects. J AIDS 2002;30 :413-20.
Dhainhaut J-F, LaTerre P-F, LaRosa S, Levy H, Garger G, Heiselman D, Kinasewitz G, Light B et al.
Clinical evaluation commitee in a large multicenter phase III trial of drotrecogin alpha (activated) in
patients with severe sepsis. Crit Care Med 31:2291-301, 2003
Dolce P, Belanger M-J, Tumanowicx, Gauthier CP, Jutras P, Masse R, Montpetit C, Bernatchez H, McColl
D, Artsob H.2003. Coxiella burnetii seroprevalence of shepherds and their flocks in the Lower SaintLawrence River region of Quebec, Canada. Can J Infect Dis 14:97-102.
Doublet, B., P. Butaye, H. Imberechts, D. Boyd, M.R. Mulvey, E. Chaslus-Dancla, and A. Cloeckaert.
2004. Characterization of Salmonella genomic island 1 multidrug resistance gene clusters from S.
enterica serovar Agona, Belgium, 1992-2002. Antimicrob. Agents Chemother. 48:2510-2517.
Doublet, B., R. Lailler, D. Meunier, A. Brisabois, D. Boyd, M.R. Mulvey, E. Chaslus-Dancla, and A.
Cloeckaert. 2003. Identification of a variant Salmonella genomic island I antibiotic resistance gene cluster
in Salmonella enterica serovar Albany. Emerging Infectious Diseases 9:585-591
Doucette KE, Aoki FY. Oseltamivir: a clinical and pharmacological perspective. Expert Opin
Pharmacother 2001; 10:1671-1683.
Doucette KE, Galbraith PA, Bow EJ, Binda BJ, Rendina A, Embil JM. Case Report: Disseminated
Zygomycosis: A Rare Cause of Infection in Patients with Hematologic Malignancies. J Trauma 2003; 55: 568570.
Dow G, Rao P, Harding G, Brunka J, Kennedy J, Alfa M, Nicolle LE. A prospective, randomized trial of
three or fourteen days ciprofloxacin for acute urinary infection in patients with spinal cord injury. Can
Infect Dis. 2004;39:658-664.
Dowell SF, Peeling RW, Boman J, Carlone GM, Fields BS, Guarner J, Hammerschlag MR, Jackson LA,
Kuo CC, Maass M, Messmer TO, Talkington DF, Tondella ML, Zaki SR; C. pneumoniae Workshop
Participants. Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for
Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clin
Infect Dis 33:492-503, 2001.
Drebot M, Lindsay R, Barker IK, Buck PA, Fearon M, Hunter F, Sockett P, Artsob H. 2003. West Nile
virus surveillance and diagnostics: a Canadian perspective. Can J Infect Dis 14:105-114.
Drebot MA, Gavrilovskaya I, Mackow ER, Chen Z, Lindsay R, Sanchez AJ, Nichol ST, Artsob H. 2001.
Genetic and serotypic characterization of Sin Nombre-like viruses in Canadian Peromyscus maniculatus
mice. Virus Research 75: 75-86.
Drebot MA, Henchal E, Hjelle B, LeDuc JW, et al. (2002) Improved clarity of meaning from the use of
both formal species names and common (vernacular) virus names in virological literature. Arch Virol
147:2465-2471.
Drebot MA, Lindsay R, Barker IK, Artsob H. 2001. Detection and characterization of a human
granulocytic ehrlichiosis (HGE) - agent from Ixodes scapularis in Ontario, Canada. Emerg Infect Dis 7:
479-480.
Drebot MA, Lindsay R, Barker IK, Buck PA, Fearon M, Hunter F, Sockett P, Artsob H. (2003). West
Nile virus surveillance and diagnostics: A Canadian perspective. Can J Infect Dis 14:105-114.
Du T, Alfa MJ. Translocation of Clostridium difficile toxin B across polarized CaCo-2 cell monolayers is
enhanced by toxin A. Can J Infect Dis. 2004;15(2):83-88.
Dubois, J., Baydack, R. S., McKenzie, E., Booth, T.F. and Jackson, M. (2003). Scrapie Infection
Investigated by Magnetic Resonance Imaging and Fourier Transform Infrared Microscopy. Vibrational
Spectroscopy 32, 95-105.
Elliott LJ, Blanchard JF, Beaudoin CM, Green CG, Nowicki DL, Matusko P, Moses S. Geographic
variations in the incidence of bacterial sexually transmitted diseases in Manitoba, Canada. Sex Transm
Infect 2002;78 Suppl 1:i139-44.
Ellison, C. A., Bradley, D.S., Fischer, J.M.M., HayGlass, K.T, and Gartner, J.G. Murine graft-versushost disease induced using interferon-g-deficient grafts features antibodies to double stranded DNA, T
helper 2-type cytokines and hypereosinophilia. Immunology. 105:63-72. 2002.
Ellison, C.A., Natuik, S.A., Fischer, J.M.M., McIntosh, A.R., Scully, S.A., Bow, E.J., Danilenko, D.M.,
Hayglass, K.T., Gartner, J.G. Effect of recombinant human keratinocyte growth factor (rHuKGF) on the
immunopathogenesis of intestinal graft-vs.-host disease induced without a preconditioning regimen. J Clin
Immunol. 2004; 24(2) 197-211.
Elsayed S., N. Hamilton, D. Boyd, and M. Mulvey. 2001. Improved primer design for multiplex PCR
analysis of vancomycin-resistant Enterococcus spp. Journal of Clinical Microbiology 39:2367-2368.
Emberley, E.D., Gietz, R.D., Campbell, J.D., HayGlass, K.T, Murphy, L.C., and Watson, P.H. RanBPM
interacts with psoriasin in vitro and their expression correlates with specific clinical features in vivo in
breast cancer. BMC Cancer. 2:28. 2002.
Embil JM, Almuneff M, Nicoll D, Makki S, Cunningham G, Wylie J, Nicolle L, Memish ZA. Methicillinresistant Staphylococcus aureus Profiles Oceans Apart – A Canadian and Saudi Arabian Experience. J
Chemother 2001; 13 (Supl 1): 28-33.
Embil JM, Crampton T, Gorski BA, Ziesmann M. The Wringer Washing Machine: An Unusual Cause of
Breast Trauma. Plast Recontstr Surg 2003; 112: 1046-1048.
Embil JM, Crampton T, Limerick B, Sarsfield S, Hershfield E, Hammond G. Letter to the Editor:
Blastomycosis in Manitoba and Northwestern Ontario. Can J Infect Dis 2003; 14:62.
Embil JM, Hurst L, Doucette K. Photoquiz: Eczema Herpeticum. Clin Infect Dis 2001; 32: 1480, 1500-1.
Embil JM, Koulack J, Greenberg H. Images in Clinical Surgery: Aortoenteric Fistula. Am J Surg 2001; 182:
75-76.
Embil JM, McLeod JA, Al-Barrak AM, Thompson GM, Aoki FY, Witicki EJ, Stranc MF, Kabani AM, Nicoll DR,
Nicolle LE. An Outbreak of Methicillin-resistant Staphylococcus aureus on a Burn Unit: Potential Role of
Contaminated Hydrotherapy Equipment. Burns 2001; 27: 681-688.
Embil JM, Reid KS. The Diabetic Foot: An Overview. COA Bulletin May/June 2002; 57: 21-23.
Embil JM, Zhanel GG, Plourde PJ and Hoban DJ. Scissors: A potential source of nosocomial infection.
Infection Control and Hospital Epidemiology 2002;23:147-151.
Embil, J. M., M. Almuneef, D. Nicoll, S. Makki, G. Cunningham, J. L. Wylie, L. Nicolle, Z. A. Memish.
2001. Methicillin-resistant Staphylococcus aureus: profiles oceans apart, comparing a Canadian and
Saudi Arabian Experience. J. Chemother. 13, Suppl. 1:28-33.
Embree JE, Bwayo J, Nagelkerke N, Njenga S, Nyange P, Ndinya-Achola J, Pamba H, Plummer F.
Lymphocyte subsets in human immunodeficiency virus type 1 infected and uninfected children in Nairobi.
Pediatr Infect Dis J 2001;20:397-403.
Embree JE, Njenga S, Datta P, Nagelkerke NJD, Ndinya-Achola JO, Mohammed Z, Ramdahin S, Bwayo
JJ, Plummer FA. Characteristics of mother, child linked to postnatal HIV transmission risk. Intl Family
Planning Perspectives 2001;27:103-4.
Eschun G, Bautista E, Duke K, Jacobs H, Light RB, Bose D, Mink SN. Effect of histamine H3 receptor
blockade on venous return and splanchnic hemodynamics in experimental sepsis. Crit Care Med 30:62836, 2002.
Fang G, Kuiken C, Weiser B, Rowland-Jones S, Plummer F, Chen CH, Kaul R, Anzala AO, Bwayo J,
Kimani J, Philpott SM, Kitchen C, Sinsheimer JS, Gaschen B, Lang D, Shi B, Kemal KS, Rostron T, Brunner
C, Brunner C, Beddows S, Sattenau Q, Paxinos E, Oyugi J, Burger H. Long-term survivors in Nairobi:
Complete HIV-1 RNA sequences and immunogenetic associations. J Infect Dis 2004;190:699-701.
Fang G, Weiser B, Kuiken C, Philpott S, Rowland-Jones S, Plummer F, Kimani J, Shi B, Kaul R, Bwayo J,
Anzala O, Burger H. Recombination following superinfection by HIV-1. AIDS 2004;18:153-9.
Faybush EM, Blanchard JF, Rawsthorne P, Bernstein CN. Generational differences in the age at
diagnosis with Ibd: genetic anticipation, bias, or temporal effects. Am J Gastroenterol 2002; 97:636-40.
Fehlner-Gardiner, C., Roshick, C., Carlson, J., Hughes, S., Belland, R., Caldwell, H. and McClarty, G. 2002.
Molecular basis defining human chlamydia trachomatis tissue tropism: A possible role for tryptophan
synthase. J Biol Chem. 277:26893-26903.
Feldmann H, Czub M, Jones S, Dick D, Garbutt M, Grolla A, Artsob H. 2002. Emerging and reemerging infectious diseases Med Microbiol Immunol 191:63-74.
Feldmann H, Jones S, Klenk HD, Schnittler HJ (2003). Ebola virus: from discovery to vaccine. Nature
Reviews Immunology 3: 677-685.
Feldmann H, Volchkov VE, Ströher U, Volchkova V, Klenk HD (2001). Biosynthesis and role of filovirus
glycoprotein. J. Gen. Virol. 82: 2839-2848.
Felmingham D, Zhanel GG and Hoban DJ. Activity of the ketolide antimicrobial telithromycin (HMR
3647) against typical community-acquired respiratory pathogens. Journal of Antmicrobial Chemotherapy
2002;48 (suppl 1):33-42.
Ferguson A, Morris CN, Assessing the role of anal intercourse in the epidemiology of AIDS in Africa. Int J
STD AIDS. 2003 Dec;14(12):856-7.
Flick K, Hooper J, Schmaljohn C. Pettersson R, Feldmann H, Flick R (2003). Rescue of Hantaan virus
minigenomes. Virology 306: 219-224.
Flick R, Flick K, Feldmann H, Elgh F (2003). Reverse genetics for Crimean-Congo hemorrhagic fever
virus. J. Virol. 77: 5997-6006.
Fonck K, Kaul R, Kimani J, Keli F, MacDonald KS, Ronald AR, Plummer FA, Kirui P, Bwayo JJ, Nugugi
EN, Moses S, Temmerman M. A Randomized, Placebo-Controlled Trial of Monthly Azithromycin
Prophylaxis to Prevent Sexually Transmitted Infections in HIV in Kenyan Sex Workers: Study design and
Baseline Findings. Intern J STD and AIDS. 2002;12:804-811.
Fong IW, Chiu B, Viira E, Tucker W, Wood H, Peeling RW. Chlamydial Heat-Shock Protein-60 Antibody
and Correlation with Chlamydia pneumoniae in Atherosclerotic Plaques. J Infect Dis 186:1469-73, 2002.
Fonseca, K., Tarrant, M., Lam, S., and Li, Y. (2002). Dural infection with influenza A and B viruses.
Pediatr Infect Dis J. 8: 795-796.
Franssen EA et al (Nagelkerke NJD). Aircraft noise around a large international airport and its impact
on general health and medication use. Occup Environ Med. 2004 May;61(5):405-13.
Funk, D., Gray, J., Plourde, P.J., Two-year trends of peripherally inserted central catheter-line
complications at a tertiary care hospital: Role of nursing expertise, Infection Control and Hospital
Epidemiology 2001;22:377-379.
Garber G, Cunningham K, Gibney N, Guimond J-G, Light RB, Magder S, Martin C, Russell J. Guidance on
patient identification and administration of recombinant activated protein C (rhAPC) for the treatment of
severe sepsis. Can J Infect Dis 13:361-372, 2002.
Garbutt M, Liebscher R, Wahl-Jensen V, Jones S, Moeller P, Wagner R, Volchkov V, Klenk HD, Feldmann
H, Stroeher U. (2004). Properties of replication-competent vesicular stomatitis virus vectors expressing
glycoproteins of filoviruses and renaviruses. J. Viro. 78: 5458-5465.
Gehua Wang, Connie Barton, and Frank Rodgers. 2002. Bacterial DNA Decontamination for Reverse
Transcription Polymerase Chain Reaction (RT-PCR). J. Microbiol. Methods 51(1):119-121.
Gehua Wang, Clifford Clark, Frank Rodgers. 2002. Detection in Escherichia coli of the Genes
Encoding the Major Virulence Factors, the Genes Defining the O157:H7 Serotype, and Components of the
Type 2 Shiga Toxin Family by Multiplex PCR. J. Clin. Microbiol. 40(10):3613-3619.
Gehua Wang, Clifford G. Clark, Chenyi Liu, Chad Pucknell, Cindy K. Munro, Tamara M.A.C. Kruk,
Richard Caldeira, David L. Woodward, and Frank G. Rodgers. 2003. Detection and characterization of
the hemolysin genes in Aeromonas hydrophila and Aeromonas sobria by multiplex PCR. J. Clin.
Microbiol. Vol. 41(3): 1048-1053.
Gehua Wang, Cliford G. Clark, Tracy M. Taylor, Chad Pucknell, Connie Batton, Lawrence Price, David
L. Woodward, and Frank G. Rodgers. 2002. Colony Multiplex PCR assay for Identification and
differenciation of Campylobacter jejuni, C. coli, C. lari, C. upsaliensis and C. fetus subsp. fetus. J. Clin.
Microbiol. 40(12): 4744-4747.
Gershon AS, De Azavedo JCS, McGeer A, Ostrowska KI, Church D, Hoban DJ, Harding GKM, Weiss K,
Abbott L, Smaill F, Gourdeau M, Murray G, Low DE. Activities of new fluoroquinolones, ketolides and
other antimicrobials against blood culture isolates of viridans group streptococci from across Canada,
2000. Antimicrob Agents Chemother. 2002:46(5):1553-1556.
Getsios D, Caro JJ, Caro G, De Wals P, Law BJ, Robert Y, Lance JMR. Instituting a routine varicella
vaccination program in Canada: an economic evaluation. Pediatr Infect Dis J, 2002(Jun). 21:542-7.
Ghanem AN, Halim IA, Embil JM, Cherneski C. Necrotizing Fasciitis. Letter to the Editor. Saudi Med J,
2002; 23: 608-610.
Gillespie GMA, Kaul R, Dong T, Yang H-B, Rostron T, Bwayo JJ, Kiama P, Peto T, Plummer FA,
McMichael AJ, Rowland-Jones SL. Cross-reactive cytotoxic T lymphocytes against a HIV-1 p24 epitope in
slow progressors with B*57. AIDS 2002 May 3;16(7):961-72.
Gillman, L. G., J. Gunton, C. Y. Turenne, J. Wolfe, and A. M. Kabani. 2001. Identification of
Mycobacterium Species by Multiple-Fluorescence PCR Single Strand Conformation Polymorphism (SSCP)
Analysis of the 16S rRNA gene. J. Clin. Microbiol. 39:3085-3091.
Greco,V., L.-K. Ng, R. Catana, H. Li, J.A. Dillon. 2003. Molecular epidemiology of Neisseria gonorrheae
isolates with plasmid-mediated tetracycline resistance in Canada: temporal and geographical trends
(1986-1997). Microb. Drug Resist. 9:353-60.
Green C, Blanchard JF, Young TK, Griffith J. Assessing the burden of diabetes among Manitoba
Registered First Nations using administrative data: current patterns and future trends. Diabetes Care
2003;26:1993-8.
Green C, Hoppa RD, Young TK, Blanchard JF. Geographic analysis of diabetes prevalence in an urban
area. Soc Sci Med 2003;57:551-60.
Greenberg D, Speert D.P, Mahenthiralingham, D. A Henry, Campbell, M.E, Scheifele D W, and the
CPS/LCDC IMPACT Monitoring network. (B. Law, IMPACT Winnipeg site investigator) Emergence of
Penicillin - Non-susceptible Streptococcus pneumoniae Invasive clones in Canada. J Clin Microbiol
2002;40:68-74.
Greene, W., Xiao, Y.,Huang, Y., McClarty, G. and Zhong, G. 2004 Chlamydia infected cells continue to
undergo mitosis and resist apoptosis induction. Infect. Immun. 72:451-60.
Grose C, S Tyler, G Peters, J Hiebert, GW Stephens, WT Ruyechan, W Jackson, J Storlie and GA Tipples.
Complete DNA sequence analyses of the first two varicella-zoster virus glycoprotein E (D150N) mutant
viruses found in North America: Evolution of genotypes with an accelerated cell spread phenotype. J Virol
78:6799-807 (2004).
Groseth A, Ströher U, Theriault S, Feldmann H (2002). Molecular characterization of an isolate from the
1989/90 epizootic of Ebola Reston virus among imported macaques. Virus Res. 87: 155-162.
Gubbins, M.J., Plummer, F.A., Yuan, X.Y., Johnstone, D., Drebot, M.A., Andonova, M., Andonov, A.,
and J.D. Berry. (2005) Molecular characterization of a panel of murine monoclonal antibodies specific for
the SARS-coronavirus. Molecular Immunology 42 (1), 125-136.
Halle JP, Merry GM, Embil JM. Round Table: Dialogues in Medical Management. Managing the Diabetic
Foot. Parkhurst Exchanged 2003; 11: 116-120.
Hamkar R., Azad T.M., Mahmoodi M., Seyedirashti S., Severini A, and Nateg R. (2002) Prevalence of
various types of human papillomavirus among cervical cancer and normal biopsy specimens in the
Mazandaran Province of Iran. Eastern Mediterranean Health J 8:805-811.
Han X, Y. Fan, S. Wang, J. Yang, X. Yang. Role of dendritic cells in infection mediated inhibition of
airway inflammation. Eur J Immunol, 34:981-989, 2004
Harding GKM, Zhanel GG, Nicolle LE, Cheang M, The Manitoba Diabetic Urinary Infection Study
Group. Antimicrobial Treatment in Diabetic Women with Asymptomatic Bacteriuria. N Engl J Med.
2002:347:1576-83.
Hary, I., Li, Y., Coulthart, M., Goyette, N., and Boivin, G. (2001). Molecular evolution of influenza
A/H3N2 viruses in the province of Quebec (Canada) during the 1997-2000 period. Virus Research. 77(1):
89-96.
Hatch, G. and McClarty, G. 2004 Chlamydia trachomatis infection accelerates phosphatidylcholine
metabolism derived from low density lipoprotein but does not affect phosphatidylcholine secretion. BMC
Microbiol. 17:8-14.
Hayden FG, Herrington DT, Coats TL, Kim K, Cooper EC, Villano SA, Liu S, Hudson S, Pevear DC, Collett
M, McKinlay M, and the Pleconaril Respiratory Infection Study Group (Aoki FY, member). Efficacy and
safety of oral pleconaril for treatment of colds due to picornaviruses in adults: results of 2 double-blind,
randomized, placebo-controlled trials. Clin Inf Dis 2003; 36:1523-1532.
HayGlass, K.T. Dynamics of immune responses: Historical perspectives in our understanding of immune
regulation. Neuroimmune Biology. 1:61-71. 2001.
HayGlass, K.T., Campbell, J.D., Gangur, V., Stinson, M.J., and Simons, F.E.R. Chemokine driven
regulation of established type 1 and type 2 cytokine responses to environmental antigens. Int. Archs.
Allergy Immunol. 124:12. 2001.
HayGlass, K.T., Haile, S., and Rempel, J.D. A role for NKT cells in regulation of ongoing type 2 immune
responses? (Aller. Clin. Immunol. Int. 15: xxx 2003).
He R, Andonov A, Traykova-Andonova M, Cao J, Cutts T, Grudesky E, Deschambaul, Y, Berry J,
Drebot M, Li X. (2004) Potent and selective inhibition of SARS coronavirus replication by
aurintricarboxylic acid. Biochem Biophys Res Commun. 6;320(4):1199-203.
He R, Dobie F, Ballantine M, Leeson A, Li Y, Bastien N, Cutts T, Andonov A, Cao J, Booth TF,
Plummer FA, Tyler S, Baker L, Li X. Analysis of multimerization of the SARS coronavirus nucleocapsid
protein. Biochem Biophys Res Commun. 2004 Apr 2;316(2):476-83.
He, R., Leeson, A., Andonov, A., Li, Y., Bastien, N., Cao, J., Osiowy, C., Dobie, F., Cutts, T.,
Ballantine, M. and Li, X. (2003) Activation of AP-1 signal transduction pathway by SARS coronavirus
nucleocapsid protein. Biochemical and Biophysical Research Communications 311, 870-876.
Heaman M, Elliott LJ, Beaudoin C, Baker L, Blanchard JF. Preventable feto-infant mortality: application
of a conceptual framework for perinatal health surveillance to Manitoba perinatal outcomes. Can J Public
Health 2002;93 (Suppl 2):S27-32.
Hermann L, Embree JE, Hazelton P, Wells B, Coombs K. Reovirus type 2 isolated from cerebrospinal fluid.
Pediatr Infect Dis J 23:373-375, 2004.
Hermann, L.L. and K.M. Coombs. (2004). Inhibition of reovirus by mycophenolic acid is associated with
the M1 genome segment. J. Virol. 78:6171-6179.
Hirst, M., Astell, C.R., Griffith, M., Coughlin, S.M., Moksa, M., Zeng, T., Smailus, D.E., Holt, R.A., Jones,
S., Marra, M.A., Petric, M., Krajden, M., Lawrence, D., Mak, A., Chow, R., Skowronski, D.M., Tweed, A.,
Goh, S., Brunham, R.C., Robinson, J., Bowes, V., Sojonky, K., Byrne, S.K., Paetzel, M., Li, Y., Konasa,
D. and Booth, T. (2004). A novel avian influenza H7N3 strain associated with an Avian Influenza
Outbreak in British Columbia. Emerging Infectious Diseases 10:2192-5, 2004.
Hoban D, Felmingham D. The PROTEKT surveillance study: antimicrobial susceptibility of Haemophilus
influenzae and Moraxella catarrhalis from community-acquired respiratory tract infections. Journal of
Antimicrobial Chemotherapy, 2002;50(Suppl S1):49-59.
Hoban D, Waites K, Felmingham D. Antimicrobial susceptibility of community-acquired respiratory tract
pathogens in North America in 1999-2000: findings of the PROTEKT surveillance study. Diagnostic
Microbiology and Infectious Diseases, 2003;45:251-259.
Hoban DJ, Biedenbach DJ, Mutnick AH, Jones RN. Pathogen of occurrence and susceptibility patterns
associated with pneumonia in hospitalized patients in North America: results of the SENTRY Antimicrobial
Surveillance Study (2000). Diagnostic Microbiology and Infectious Diseases, 2003;45:279-285.
Hoban DJ, Bouchillon SK, Johnson BM, Johnson GG, Butler DL, Saunders KA, Poupard JA, and the
Surveillance Study Research Group. A comparative in vitro surveillance study of amoxicillin-clavulanic
acid and four oral comparators against 21,232 recent clinical aerobic isolates from Europe. European
Journal of Clinical Microbiology and Infectious Diseases, 2003;22(4):261-267.
Hoban DJ, Bouchillon SK, Johnson JL, Zhanel GG, Butler DL, Miller Dl, Poupard JA and the gemifloxacin
surveillance study research group. Comparative in-vitro activity of gemifloxacin ciprofloxacin levofloxacin
and ofloxacin in a North America surveillance study. Diagnostic Microbiology and Infectious Diseases
2001;40:51-57.
Hoban DJ, Bouchillon SK, Johnson JL, Zhanel GG, Butler DL, Miller Dl, Poupard JA and the gemifloxacin
surveillance study research group. Comparative in-vitro potency of gemifloxacin and fluoroquinolones
against recent European clinical isolates from a global surveillance study. European Journal of Clinical
Microbiology and Infectious Diseases 2001;20:814-819.
Hoban DJ, Bouchillon SK, Johnson JL, Zhanel GG, Butler DL, Saunders KA, Miller LA, Poupard JA, The
Surveillance Study Research Group. Comparative in vitro potency of amoxicillin-clavulanic acid and four
oral agents against recent North American clinical isolates from a global surveillance study. International
Journal of Antimicrobial Agents, 2003;21:425-433.
Hoban DJ, Doern GV, Fluit AC, Roussel-Delvallez M, and Jones RN. World Wide Prevalence of
Antimicrobial Resistance in Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis:
Report from the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clinical Infectious Diseases,
2001;32(S2):S81-S93.
Hoban DJ, Wierzbowski AK, Nichol K, Zhanel GG. Macrolide resistant Streptococcus pneumoniae in
Canada during 1998-99: prevalence of mefA and ermB and susceptibilities to ketolides. Antimicrobial
Agents and Chemotherapy, 2001;45:2147-2150.
Hoban DJ. Antibiotics and collateral damage. Clinical Cornerstone, 2003;Suppl 3:S12-S-20.
Hoban DJ. Epidemiology of Resistance in the Hospital. Pharmaceutical News, 2002;9:239-246.
Hoban DJ. Prevalence and characterization of macrolide resistance in clinical isolates of Streptococcus
pneumoniae and Streptococcus pyogenes. Journal of Chemotherapy, 2002;14(Suppl 3):25-30.
Hodgins S, Peeling RW, Dery S, Bernier F, LeBrecque A, Proulx J-F, Joly J, Alary M, Mabey D. The
utility of mass screening for Chlamydia control in high prevalence communities. Sex Transm Inf 78
(Suppl 1):164-8, 2002.
Hoebee B et al (Nagelkerke NJD). Association of severe respiratory syncytial virus bronchiolitis with
interleukin-4 and interleukin-4 receptor alpha polymorphisms. J Infect Dis. 2003 Jan 1;187(1):2-11..
Hoebee B et al (Nagelkerke NJD). Influence of promoter variants of interleukin-10, interleukin-9, and
tumor necrosis factor-alpha genes on respiratory syncytial virus bronchiolitis. J Infect Dis. 2004
189(2):239-47.
Hogbom, M., Stenmark, P., McClarty, G. and Nordlund, P. 2004. The Chlamydia ribonucleotide reductase-a
novel radical site in Class-I R2s. Science 305:245-248
Hsiao, M., Su, W.N., Forooghian, F., Bader S., Rempel, J., HayGlass, K.T., Gilman, A. and Schultz, K.
Evaluation for synergistic suppression of T cell responses to minor histocompatibility antigens by
chloroquine in combination with tacrolimus and a rapamycin derivative, SDZ-RAD. Bone Marrow
Transplant. 30:905-12. 2002.
Hughes W.T., Armstrong D., Bodey G.P., Bow E.J., Brown A.E., Calandra T., Feld R., Pizzo P.A., Rolston
K.V.I., Shenep J.L., Young L.S.: 2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic
Patients with Cancer. Clin Infect Dis 2002; 34(6):730-751.
Hutchinson, J., W. Runge, M.R. Mulvey, G. Norris M. Yetman, F. Lepine, N. Valkova. 2004. Burkholderia
cepacia Infections Associated with Intrinsically Contaminated Ultrasound Gel - the Role of Microbial
Degradation of Parabens. Infection Control and Hospital Epidemiology. 25:291-296.
Hyland M, Ofner-Agostini M, Miller M, Paton S, Gourdeau M, Ishak M, the Canadian Hospital Epidemiology
Committee (M. Mulvey, J. Embil, J.E. Embree, members), and the Canadian Nosocomial Infection
Surveillance Program, Health Canada. 2001. Nosocomial Clostridium difficile- associated diarrhea (NCDAD) in Canada- The results of the Canadian Nosocomial Infection Surveillance Program (CNISP) 1997
N-CDAD prevalence surveillance project. Canadian Journal of Infectious Diseases. 12:81-88.
Iliffe-Lee, E.R. and McClarty, G. 2002. Pyruvate kinase from Chlamydia trachomatis is activated by
fructose-2,6-bisphosphate. Mol Microbiol.44: 819-28.
Ilnyckyj A, Graff LA, Blanchard JF, Bernstein CN. Therapeutic value of a gastroenterology consultation
in irritable bowel syndrome. Aliment Pharmacol Ther 2003;17:871-80.
INFECTIOUS DISEASES AND IMMUNIZATION COMMITTEE, (J EMBREE, CHAIR), CANADIAN
PAEDIATRIC SOCIETY. Therapy of suspected bacterial meningitis in Canadian children six weeks of age
and older. (ID 2001-01) Paediatr Child Health 6: 147-152, 2001.
INFECTIOUS DISEASES AND IMMUNIZATION COMMITTEE, (J EMBREE, CHAIR), CANADIAN
PAEDIATRIC SOCIETY. Paediatric Infectious Disease Notes. Pertussis immunization for adolescents: What
are we waiting for?. Paediatr Child Health 6: 184-186, 2001 & Can J Infect Dis 12:74-76, 2001.
INFECTIOUS DISEASES AND IMMUNIZATION COMMITTEE, (J EMBREE, CHAIR), CANADIAN
PAEDIATRIC SOCIETY. Bugs in our meal: Food for thought. (ID 2001-02) Paediatr Child Health 6: 214217, 2001.
INFECTIOUS DISEASES AND IMMUNIZATION COMMITTEE, (J EMBREE, CHAIR), CANADIAN
PAEDIATRIC SOCIETY. Paediatric Infectious Disease Notes. Flesh-eating disease: A note on necrotizing
fasciitis. Paediatr Child Health 6: 184-186, 2001 & Can J Infect Dis 12:136-140, 2001.
INFECTIOUS DISEASES AND IMMUNIZATION COMMITTEE, (J EMBREE, CHAIR), CANADIAN
PAEDIATRIC SOCIETY. EMBREE JE, principal author. Paediatric Infectious Disease Notes. Its time for a
national immunization strategy. Paediatr Child Health 6: 316-318, 2001 & Can J Infect Dis 12:208-210,
2001.
INFECTIOUS DISEASES AND IMMUNIZATION COMMITTEE, (J EMBREE, CHAIR), CANADIAN
PAEDIATRIC SOCIETY. EMBREE JE, principal author. Measles-mumps-rubella vaccine and autistic
spectrum disorder: A hypothesis only. (ID 2001-03) Paediatr Child Health 6: 387-389, 2001.
INFECTIOUS DISEASES AND IMMUNIZATION COMMITTEE, (J EMBREE, CHAIR), CANADIAN
PAEDIATRIC SOCIETY. Testing for human immunodeficiency virus type 1 (HIV-1) infection in pregnancy.
(ID 2001-04) Paediatr Child Health 6: 184-186, 2001.
INFECTIOUS DISEASES AND IMMUNIZATION COMMITTEE, (J EMBREE, CHAIR), CANADIAN
PAEDIATRIC SOCIETY. Paediatric Infectious Disease Notes. Historical review of croup. Paediatr Child
Health 6: 271-273, 2001 & Can J Infect Dis 12:337-339, 2001.
INFECTIOUS DISEASES AND IMMUNIZATION COMMITTEE, (J EMBREE, CHAIR), CANADIAN
PAEDIATRIC SOCIETY. Paediatric Infectious Disease Notes. Allergy to antibiotics in children: perception
versus reality. Paediatr Child Health 7: 233-237, 2002 & Can J Infect Dis 13:160-163, 2002.
INFECTIOUS DISEASES AND IMMUNIZATION COMMITTEE, (J EMBREE, CHAIR), CANADIAN
PAEDIATRIC SOCIETY. Paediatric Infectious Disease Notes. Preventing group B streptococcal infections.
New recommendations. Paediatr Child Health 7: 380-383, 2002 & Can J Infect Dis 13:232-235, 2002.
INFECTIOUS DISEASES AND IMMUNIZATION COMMITTEE, (J EMBREE, CHAIR), CANADIAN
PAEDIATRIC SOCIETY.. EMBREE JE, principal author. Pneumococcal vaccine for children.(ID 2002-1).
Paediatr Child Health 7: 417-518, 2002
INFECTIOUS DISEASES AND IMMUNIZATION COMMITTEE, (J EMBREE, CHAIR), CANADIAN
PAEDIATRIC SOCIETY.. Meningococcal vaccine for children.(ID 2002-2). Paediatr Child Health 7: 425427, 2002
INFECTIOUS DISEASES AND IMMUNIZATION COMMITTEE, (J EMBREE, CHAIR), CANADIAN
PAEDIATRIC SOCIETY. Paediatric Infectious Disease Notes. From soap and water to waterless
agents:update on hand hygiene in health care settings. Paediatr Child Health 7:511-512, 2002 & Can J
Infect Dis 13:285-286, 2002.
INFECTIOUS DISEASES AND IMMUNIZATION COMMITTEE, (J EMBREE, CHAIR), CANADIAN
PAEDIATRIC SOCIETY. EMBREE JE, Tan B, principal authors. Paediatric Infectious Disease Notes.
Vaccine schedules. Paediatr Child Health 8:13-15,2003 & Can J Infect Dis 13:358-360, 2002.
INFECTIOUS DISEASES AND IMMUNIZATION COMMITTEE, (J EMBREE, CHAIR), CANADIAN
PAEDIATRIC SOCIETY.Paediatric Infectious Disease Notes. Transfusion and risk of infection in Canada.
Paediatr Child Health 8: 135-137, 2003 & Can J Infect Dis 14:81-83, 2003.
INFECTIOUS DISEASES AND IMMUNIZATION COMMITTEE, (J EMBREE, CHAIR), CANADIAN
PAEDIATRIC SOCIETY.Paediatric Infectious Disease Notes. Current management of Herpes simplex
infection in pregnant women and their newborn infants: What’s hot and what’s not. Paediatr Child Health
8: 339-342, 2003 & Can J Infect Dis 14: 197-200, 2003.
INFECTIOUS DISEASES AND IMMUNIZATION COMMITTEE, (J EMBREE, CHAIR), CANADIAN
PAEDIATRIC SOCIETY.y. Acelluar pertussis vaccine for adolescents (ID 2003-2). Paediatr Child Health
8:378,2003
INFECTIOUS DISEASES AND IMMUNIZATION COMMITTEE, (J EMBREE, CHAIR), CANADIAN
PAEDIATRIC SOCIETY.Varicella vaccine for children (ID 2003-1). Paediatr Child Health 8:384,2003.
INFECTIOUS DISEASES AND IMMUNIZATION COMMITTEE, (J EMBREE, CHAIR), CANADIAN
PAEDIATRIC SOCIETY.Paediatric Infectious Disease Notes. West Nile virus – Mosquitoes no longer just an
annoyance! Paediatr Child Health 8: 267-270, 2003 & Can J Infect Dis 14: 150-153, 2003.
INFECTIOUS DISEASES AND IMMUNIZATION COMMITTEE, (J EMBREE, CHAIR), CANADIAN
PAEDIATRIC SOCIETY.Paediatric Infectious Disease Notes. The Red Book is coming to town. Paediatr
Child Health 8: 267-270, 2003 & Can J Infect Dis 14:252-253 2003.
INFECTIOUS DISEASES AND IMMUNIZATION COMMITTEE, (J EMBREE, CHAIR), CANADIAN
PAEDIATRIC SOCIETY.. Use of paliviziumab in children with congenital heart disease (ID 2003-2).
Paediatr Child Health 8:631-633, 2003.
INFECTIOUS DISEASES AND IMMUNIZATION COMMITTEE, (J EMBREE, CHAIR), CANADIAN
PAEDIATRIC SOCIETY.. Paediatric Infectious Disease Notes. Routine Immunization Schedule: Update
2004. Paediatr Child Health 9: 17-20, 2004 & Can J Infect Dis 15:17-20,2004.
INFECTIOUS DISEASES AND IMMUNIZATION COMMITTEE, (J EMBREE, CHAIR), CANADIAN
PAEDIATRIC SOCIETY.. Paediatric Infectious Disease Notes. Transfusion and risk of infection in Canada:
UPDATE 2004. Paediatr Child Health 9:145-148, 2004 & Can J Infect Dis 15: 79-82, 2004.
INFECTIOUS DISEASES AND IMMUNIZATION COMMITTEE, (J EMBREE, CHAIR), CANADIAN
PAEDIATRIC SOCIETY.y. Paediatric Infectious Disease Notes. West Nile update – Preparing for summer
2004. Paediatr Child Health 9:301-302, 2004 & Can J Infect Dis & Med Micro 15: 165-166, 2004.
Jacobi CE et al (Nagelkerke NJD). Prevalence of family histories of breast cancer in the general
population and the incidence of related seeking of health care. J Med Genet. 2003 Jul;40(7):E83
Jadavji T, Scheifele D, Halperin S and members of IMPACT(B. Law, IMPACT Winnipeg site investigator).
Thrombocytopenia after immunization of Canadian children, 1992-2001. Pediatric Journal of Infectious
Disease, 2003; 22:119-123.
Jassal DS, Low M, Ross LL, Ziesmann M, Embil JM. Calcific Myonecrosis: Case Report and Review. Ann
Plast Surg 2001; 46: 174-177.
Jassal DS, McGinn G, Embil JM. Pituitary Apoplexy Masquerading as Meningoencephalitis. Headache: The
Journal of Head and Face Pain 2004 44: 75-78.
Jassal DS, Ross L, Aoki F, Embil JM. Dermacase. Herpes Simplex Virus. Can Fam Phys. 41:2475, 2001.
Jassal R, Jassal DS, Embil JM. Toilet Seat Syndrome: Renal Failure, Perineal Gangrene and Sciatic
Neuropathy. Am J Med 2001; 110: 414-5.
Jha P. et al (Nagelkerke NJD). Public health. Reducing HIV transmission in developing countries.
Science. 2001 Apr 13;292(5515):224-5.
Jiang Y, T-R Xu, B. Lu, D. Mymin, E. A. Kroeger, T. Dembinski, X. Yang, G. M. Gatch, and P.C. Choy.
Cyclooxygenase expression is elevated in retinoic acid differentiated U937 cells. Biochim Biophys Acta
33:51-60, 2003.
Johnson, P.M., M.S. Carpenter, G. Hirsch and T. Lee. 2002. Recipient cells form the intimal proliferative
lesion in the rat aortic model of allograft arteriosclerosis. Am. J. Transplant 2(3):207-14.
Johnston J.B., J. W. Barrett, Wen Chang, Che-Sheng Chung, W. Zeng, Jennefer Masters, M. Mann, Fuan
Wang, Jingxin Cao, and Grant McFadden. Role of the Serin-Threonine Kinase PAK-1 in Myxoma Virus
Replication. Journal of Virology 2003, 77(10):5877-5888
Johnston JB, Silva C, Hiebert T, Buist R, Dawood MR, Peeling J and Power C (2002). Neurovirulence
depends on virus input titer in brain in feline immunodeficiency virus infection: Evidence for activation of
innate immunity and neural injury. J Nurovirol. 8: 420-431.
Jolly A.M. and J. L. Wylie. 2001. Sampling individuals within large sexual networks: an evaluation of
four approaches. Sex. Trans. Dis. 28:200-207.
Jolly A.M. and J. L. Wylie. 2002. Gonorrhoea and chlamydia core groups and sexual networks in
Manitoba. Sex. Trans. Infect. 78(Suppl I):1145-1151. Conference proceedings: Phase specific
strategies for the prevention, control, and elimination of sexually transmitted diseases, Rome, Italy.
Jolly, A. M., S. A. Muth, J. L. Wylie, J. Potterat. 2001. Sexual networks and sexually transmitted
infections; a tale of two cities. J. Urban Health. 78:433-445.
Jonker MA et al (Nagelkerke NJD). Modeling familial clustered breast cancer using published data.
Cancer Epidemiology, Biomarkers and prevention. 2003 Dec;12(12):1479-85
Julian J.L., O.J. Cohen, Z-l Nie, J.G. Weaver, T.S. Gomez, X-J Yao, D. Lynch, A.A. Pilon, N. Hawley, J.E.
Kim, Z-X Chen, M. Montpetit, J. Sanchez-Dardon, E.A. Cohen, and A.D. Badley. 2003. Vpr mutation R77Q
is associated with long term non progressive HIV infection and an impaired ability to induce T cell
depletion in vivo. J. Clin. Invest. 111: 1547-1554.
Karmali MA, Mascarenhas M, Shen S, Ziebell K, Johnson S, Reid-Smith R, Isaac-Renton J, Clark C, Rahn
K, Kaper JB. 2003 Association of genomic O island 122 of Escherichia coli EDL 933 with verotoxinproducing Escherichia coli seropathotypes that are linked to epidemic and/or serious disease. J Clin
Microbiol 41:4930-4940.
Karpinsky, M., D. Rush, J. Jeffery, D. Pochinco, D. Milley, and P. Nickerson. 2003. Heightened
Peripheral Blood Lymphocyte CD69 Expression is Neither Sensitive nor Specific as a Noninvasive
Diagnostic Test for Renal Allograft Rejection. Journal of the American Society for Nephrology 14(1):22633
Karunakaran K, Blanchard J, Raudonikiene A, Lu H, Shen C, Murdin A, Brunham RC. Molecular
detection and seroepidemiology of the Chlamydia pneumoniae bacteriophage (MCpn1). J Clin Microbiol
2002;40:4010-4.
Kashiwada Y, Chiyo J, Ikeshiro Y, Nagao T, Okabe H, Cosentino LM, Fowke K, Lee KH. 3,28-Di-O(dimethylsuccinyl)-betulin isomers as anti-HIV agents. Bioorg Med Chem Lett. 2001,11:183-5.
Kashiwada Y, Yamazaki K, Ikeshiro Y, Yamagishi T, Fujioka T, Mihashi K, Mizuki K, Cosentino LM, Fowke
K, Morris-Natschke SL, Lee KH. Isolation of rhododaurichromanic acid B and the anti-HIV principles
rhododaurichromanic acid A and rhododaurichromenic acid from Rhododendron dauricum. Tetrahedron
57 (8): 1559-1563 FEB 18 2001
Kaul R, Dong T, Plummer FA, Kimani J, Rostron T, Kiama P, Njagi E, Irungu E, Farah B, Oyugi J,
Chakraborty R, MacDonald KS, Bwayo JJ, McMichael AJ, Rowland-Jones SL. CD8+ lymphocytes respond
to different HIV epitopes in seronegative and infected subjects. J Clin Invest 2001;107:1303-10.
Kaul R, Kimani J, Nagelkerke NJ, Fonck K, Keli F, MacDonald KS, Ronald AR, Plummer FA, Bwayo JJ,
Ngugi EN, Temmerman M, Moses S. Reduced HIV risk-taking and low HIV incidence after enrollment
and risk-reduction counseling in a sexually transmitted disease prevention trial in Nairobi, Kenya. J AIDS
2002;30:69-72.
Kaul R, Kimani J, Nagelkerke NJ, Fonck K, Keli F, MacDonald KS, Ronald AR, Plummer FA, Bwayo JJ,
Ngugi EN, Temmerman M, Moses S. Reduced HIV risk-taking and low HIV incidence after enrollment and
risk-reduction counseling in a sexually transmitted disease prevention trial in Nairobi, Kenya. J Acquir
Immune Defic Syndr. 2002 May 1;30(1):69-72.
Kaul R, Kimani J, Nagelkerke NJ, Fonck K, Ngugi EN, Keli F, MacDonald KS, Maclean IW, Bwayo JJ,
Temmerman M, Ronald AR, Moses S; Kibera HIV Study Group. Monthly antibiotic chemoprophylaxis
and incidence of sexually transmitted infections and HIV-1 infection in Kenyan sex workers: a randomized
controlled trial. JAMA. 2004 Jun 2;291(21):2555-62.
Kaul R, Plummer F, Clerici M, Bomsel M, Lopalco L, Broliden K. Mucosal IgA in exposed, uninfected
subjects: evidence for a role in protection against HIV infection. AIDS 2001;15:431-2.
Kaul R, Rowland-Jones S, Kimani J, Fowke K, Dong T, Kiama P, Rutherford J, Njagi E, Mwangi F,
Rostron T, Onyango J, Oyugi J, MacDonald KS, Bwayo JJ, Plummer F. New insights into HIV-1 specific
cytotoxic T-lymphocyte responses in exposed, persistently seronegative Kenyan sex workers. Immunol
Lett 2001;79:3-13.
Kaul R, Rowland-Jones SL, Gillespie G, Kimani J, Dong T, Kiama P, Simonsen N, Bwayo JJ, McMichael
AJ, Plummer FA. Gonococcal cervicitis is associated with reduced systemic CD8+ T cell responses in
human immunodeficiency virus type 1-infected and exposed, uninfected sex workers. J Infect Dis
2002;185(10):1525-9.
Kaul R, Rowland-Jones SL, Kimani J, Dong T, Yang H-B, Kiama P, Rostron T, Njagi E, Bwayo JJ,
MacDonald KS, McMichael AJ, Plummer FA. Late seroconversion in HIV-resistant Nairobi prostitutes
despite pre-existing HIV-specific CD8(+) responses. J Clin Invest 2001;107:341-9.
Kaul R, Thottingal P, Kimani J, Kiama P, Waigwa CW, Bwayo JJ, Plummer FA, Rowland-Jones SL.
Quantitative ex vivo analysis of functional virus-specific CD8 T lymphocytes in the blood and genital tract
of HIV-infected women. AIDS 2003;17:1139-44.
Keahey L, Bulloch B, Jacobson R, Tenenbein M, Kabani A. 2002. Diagnostic accuracy of a rapid antigen
test for GABHS performed by nurses in a pediatric ED. Am J Emerg Med 20(2):128-130.
Kellner JD, Scheifele DW, Halperin SA, Lebel MH, Moore D, Le Saux N, Ford-Jones EL, Law B, Vaudry W
and Members of IMPACT Outcome of Penicillin-Nonsusceptible Streptococcus pneumoniae Meningitis: A
Nested Case-Control Study. Pediatric Infectious Disease Journal, 2002; 21:903-9.
Kendall T, Morris CN, and Bratstein P, Constrained Choices and Communication: HIV+ Women
Accessing Complementary and Alternative Medicine in British Columbia , Journal of Canadian Women’s
Studies ,Summer/Fall 2001 Volume 21, Number 2, p.96-103.
King A, P Varughese, G DeSerres, G Tipples, J Waters and Members of the Working Group on Measles
Elimination. Measles elimination in Canada. J Inf Dis 189 (Suppl. 1):S236-S242 (2004).
Kinsella E, Martin SG, Grolla A, Czub M, Feldmann H, Flick R (2004). Sequence determination of the
Crimean-Congo hemorrhagic fever virus L segment. Virology 321: 23-28.
Klepser ME, Lewis RE, Ernst EJ, Petzold CR, Bailey EM, Burgess DS, Carver PL, Lacy MK, Mercier RC, Nicolau
DP, Zhanel GG, Pfaller MA. Multi-center evaluation of standardized methods for conducting antifungal timekill studies. Antimicrobial Agents and Chemotherapy 2001;45:201-203.
Koesters S, Rutherford WJ, Fowke KR. Development of a novel allo-independent HIV-1 virus for use in
immunoassays. J. Immunol Meth. 264: 69-76, 2002.
Koppen S. et al (Nagelkerke NJD). No epidemiological evidence for infant vaccinations to cause allergic
disease. Vaccine. 2004 Sep 3;22(25-26):3375-85.
Koren G, Money D, Boucher M, Aoki FY, Petric M, Innocencion G, Woloski M, Remple V, Pelland F, Geist
R, Ho, T, Bar-Oz B, Loebstein R. Serum concentrations, efficacy, and safety of a new, intravenously
administered varicella zoster immune globulin in pregnant women. J Clin Pharmacol 2002; 42:267-274.
Krokhin, O., Li, Y., Andonov, A., Feldman, H., Flick, R., Jones, S., Stroeher, U., Bastien, N., Dasuri, K.
V. N., Cheng, K., Simonsen, J. N., Perreault, H., Wilkins, J., Werner, Ens., Plummer, F. and Standing,
K. G. (2003). Mass spectrometric characterization of protein from SARS virus. Molecular and Cellular
Proteomics 2, 346-356.
Ksiazek TG, Erdman D, Goldsmeith CS, and the SARS Working Group (F. Plummer, member). A novel
coronavirus associated with severe acute respiratory syndrome. NEJM 2003;348;1953-55; N Engl J Med
2004;348;1953-66; published on web @ www.nejm.org on April 10, 2003.
Kumar D, Drebot MA, Wong SJ, Lim G, Artsob H, Buck P, Humar A. 2004. A seroprevalence study of
West Nile virus infection in solid organ transplant recipients. American Journal of Transplantation 4:1883888.
Kuno G, Artsob H, Karabatsos N, Tsuchiya KR, Chang G-JJ. 2001. Genomic sequencing of deer tick virus
and the phylogeny of the Powassan-related viruses of North America. Am Journal Trop Med Hyg 65:671676.
Kurbis, C. A. and J. L. Wylie. 2001. Community-based outbreak of methicillin resistant Staphylococcus
aureus in Manitoba, Canada. Can. J. Infect. Dis. 12: 149-152.
Kwok, A.Y.C., J.T. Wilson, M. Coulthart, L.-K. Ng., L. Mutharia, and A W. Chow. 2002. Phylogenetic
Study and Identification of Human Pathogenic Vibrio Species Based on Partial hsp60 Gene Sequences.
Can J Microbiol. 48:903-10.
Lai-King Ng, P. Sawatzky, I Martin, S Booth (2002). Characterization of Ciprofloxacin resistance in
Neisseria gonorrhoeae Isolates in Canada. Sexually Transmitted Diseases,29(12), 780-788.
Lai-King, N., Martin, I., Lau, A. and the National Gonococcal Surveillance Program Members (Shaw, C.,
Tyrrel, G., Wylie, J. L., Jamieson, F., Brown, S., Turcotte, P., Forward, K., Hardy, G. J., Abbott, L., and
Ratnam, S). 2003. Trends of chromosomally mediated antimicrobial resistance in Neisseria gonorrhoeae
in Canada. Sex. Trans. Dis. 30:896-900.
Langlois JP, Fahrig L, Merriam G, Artsob H. 2001. Landscape structure influences continental distribution
of hantavirus in deer mice. Landscape Ecology 16: 255-266.
Langton SD et al (Nagelkerke NJD). Analysing collaborative trials for qualitative microbiological
methods: accordance and concordance. Int. J. Food Microbiology, 2002, 79: 175-181.
Laverdiere M, Hoban D, Restieri C, Habel F. In vitro activity of three new triazoles and one echinocandin
against Candida bloodstream isolates from cancer patients. Journal of Antimicrobial Chemotherapy,
2002;50:119-123.
Law BJ, Carbonell Estrany X, Simoes EAF. An update on respiratory syncytial virus epidemiology: a
developed country perspective. Respir Med 2002(Apr); 96: Suppl B: S1-7.
Le Saux N, Barrowman NJ, Moore DL, Whiting S, Scheifele D, Halperin S, for Members of the Canadian
Paediatric Society/Health Canada Immunization Monitoring Program, Active (IMPACT) [B. Law, member
of IMPACT]. Decrease in Hospital Admissions for Febrile Seizures and Reports of HypotonicHyporesponsive Episodes Presenting to Hospital Emergency Departments Since Switching to Acellular
Pertussis Vaccine in Canada: A Report From IMPACT. Pediatrics, 2003; 112:e348-53. (Pediatrics
electronic edition, http://www.pediatrics.org/cgi/content/ful/112/5/e348)
Leighton FA, Artsob H, Chu MC, Olson JG. 2001. A serological survey of rural dogs and cats on the
southwest Canadian prairie for zoonotic pathogens. Can J Pub Hlth 92 : 67-71.
Leone PA, Trottin S, Miller, JM and the International Valaciclovir Study Group (Aoki FY, member).
Valaciclovir for episodic treatment of Genital Herpes: A shorter 3-day treatment course compared with 5day treatment. Clin Inf Dis 2002; 34:958-962.
Lewkowich, I., Rempel, J.D. and HayGlass, K.T. Antigen specific versus total immunoglobulin
synthesis: Total IgE and IgG1, but not IgG2a levels predict murine antigen specific responses. Int. Arch.
Aller. Immunol. 2004 Feb;133(2):145-53. Epub 2004 Jan 26.
Lewkowich, I., Rempel, J.D. and HayGlass, K.T. In vivo IgE levels in exogenous antigen stimulated
responses: Measurement of total IgE as a valid, simple surrogate for Ag-specific IgE. J. Immunol.
Methods. 2004 Mar;286(1-2):123-32.
Lewkowich, I.P. , Campbell D.J. and HayGlass, K.T. Comparison of chemiluminescent assays and
colorimetric ELISAs for quantification of murine IL-12, human IL-4 and murine IL-4: chemiluminescent
substrates provide markedly enhanced sensitivity. J. Immunol. Methods. 247:111-118. 2001.
Lewkowich, I.P. and HayGlass, K.T. Cytokine based immunotherapy of allergic disease. Archivum
Immunologiae et Therapiae Experimentalis. 49: 293-302. 2001.
Lewkowich, I.P. and HayGlass, K.T. IFNγ and IL-18 directly limit the induction of type 2 immunity in
vivo. Eur. J. Immunology. 32:3536-45. 2001.
Li, Y., Lee, C., Loeb, M., Phillips, A., Nesbitt, J., Smith, K., Fearon, M., McArthur, M.M., Mazzulli, T., and
McGeer, A. (2001). Zanamivir use during transmission of amantadine-resistant influenza A in a nursing
home. Options for the Control of Influenza IV (Osterhaus A, Nancy C, and Hampson A, ed), Elsevier
Science, New York. pp: 823-828.
Lin D, Li L, Dick D, Shope RE, Feldmann H, Barrett AD, Holbrook MR (2003). Analysis of the complete
genome of the tick-borne flavivirus Omsk hemorrhagic fever virus. Virology 313: 81-90.
Lindsay RL, Barker IK, Nayar G, Drebot MA, Calvin S, Scammell C, Sachvie C, Scammell-La Fleur,
Dibernardo A, Andonova M, Artsob H. 2003. Field evaluation of an antigen capture assay to detect West
Nile virus in dead corvids. Emerging Infect Dis 9:1406-1410.
Lindsay RL, Drebot MA, Weiss E, Artsob H. 2001. Hantavirus pulmonary syndrome in Manitoba. Can J
Infect Dis 12: 169-173.
Lipsky BA, Berendt AR, Derry HG, Embil JM, Joseph WS, Karchmer AW, LeFrock JL, Lew DP, Mader JT,
Norden C, Tan JS. Infectious Diseases of America Guideline: Diagnosing and Treating Diabetic Foot
Infections. Clin Infect Dis 2004; 39: 885-910.
Livesley N, Morris CN, Antiretroviral therapy in a primary care clinic in rural South Africa.
AIDS. 2003 Sep 5;17(13):2005-6.
Livesley N, Morris CN, Antiretroviral therapy in the private sector of resource-limited settings.
AIDS. 2004 Feb 20;18(3):581-2.
Lo E, Rezai K, Evans AT, Madariaga MG, Phillips M, Brobbey W, Schwartz DN, Wang Y, Weinstein RA,
Trenholme GM. “Why Don’t They Listen?” Adherence to Recommendations of Infectious Disease
Consultations. CID 2004; 38:1212-18.
Löber C, Anheier B, Lindow S, Feldmann H (2001). The hantavirus glycoprotein precursor is cleaved at
the conserved pentapeptide ‚WAASA‘. Virology 289: 224-229.
Loeb, M., Bentley, D.W., Bradley, S., Crossley, K., Gantz, N., Garibaldi, R., McGeer, A., Muder, R.,
Mylotte, J., Nicolle, L.E., Nurse, B., Paton, S., Simor, A.E., Smith, P., Strausbaugh, L. Development of
minimum criteria for the intiation of antibiotics in residents of long term care facilities: results of a
consensus conference. Infect Control Hosp Epidemiol 2001; 22: 120-124.
Loeb, M., Brazil, K, Durand, P., Gordon, M., Krueger, P., Lewis, D, Lohfeld, L., McGeer, A., Nicolle, L.,
Papaioannou, A., Simor, A.E. Identifying research priorities on infections in older adults: Proceedings of
an interdisciplinary workshop. BMC Geriatrics (2001) 1:1 (14 Aug 2001);
http://www.biomedcentral.com/1471-2318/1/1/.
Loparev VN, A Gonzalez, M Deleon-Carnes, GA Tipples, H Fickenscher, EG Torfason and DS Schmid.
Three major genotypes of varicella-zoster virus: geographical clustering and strategies for genotyping. J
Virol 78:8349-58 (2004).
Low DE, De Azavedo J, Weiss K, Mazzulli T, Kuhn M, Church D, Forward K, Zhanel G, Simor A, The
Canadian Bacterial Diseases Network (Harding G – member), McGeer A. Antimicrobial Resistance
Among Clinical Isolates of Streptococcus pneumoniae in Canada during 2000. Antimicrob Agents
Chemother. 2002:46(5);1295-1301.
Lucht A, Grunow R, Moeller P, Feldmann H, Becker S (2003). Development, characterization ands use of
monoclonal VP40-antibodies for the detection of Ebola virus. J. Virol. Meth.111: 21-28.
Luo M, Blanchard J, Brunham K, Pan Y, Shen CX, Lu H, Brunham RC. Two-step high resolution
sequence-based HLA-DRB typing of exon 2 DNA with taxonomy-based sequence analysis allele
assignment. Hum Immunol 2001;62:1294-310.
Luo M, Cohen CR, Narayansingh MJ, Pan S, McKinnon L, Brunham RC, Plummer FA. Identification of
a novel HLA-DQA1 null allele, DQA1*0403N, from an East African woman. Tissue Antigens 2004;63:60911.
Luo M, Embree J, Ramdahin S, Ndinya-Achola J, Njenga S, Bwayo JJ, Pan S Mao X, Cheang M, Stuart T,
Brunham RC, Plummer FA. HLA-A and HLA-B in Kenya, Africa: Allele frequencies and identification of
HLA-B*1567 and HLA-B*4426. Tissue Antigens 2002;59:370-80.
Luo M, Embree JE, Ramdahin S, Ndinya-Achola J, Njenga S, Bwayo JB, Jacobson K, Kwan L, Schroeder M,
Pan S, Narayansingh MJ, Iqbal S, Brunham RC, Plummer FA. HLA Class I and Class II alleles in Kenya,
Africa: Disparity in diversity and evolutionary implications. HLA 2002. Immunobiology of the Human MHC.
13th IHWG, Seattle.
Luo M, Kimani J, Fowke K, Ball B, MacDonnald K, Ramdahin S, Ndinya-Achola J, Njenga S, Bwayo JB,
Embree J, Plummer FA. Evolutionary implications of current HIV epidemic on the population of Kenya,
East Africa: study of population genetics by sequence-based DRB typing. Hum Immunol. 2003;64
(Suppl):S20.
Luo M, Ramdahin S, Iqbal S, Pan Y, Jacobson K, Narayansingh MJ, Schroeder M, Brunham RC, Embree
JE, Plummer FA. High resolution sequence-based DPB1 typing identified two novel DPB1 alleles,
DPB1*9401 and DPB1*9501, from a Kenyan population. Tissue Antigens 62:182-184, 2003.
Luo, L., Li, Y., and Kang, C.Y. (2003). Budding and secretion of HIV Gag-Env virus-like particles from
human adenovirus infected cells. Virus Research. 92(1): 75-82.
Luscher MA, MacDonald KS, Bwayo JJ, Plummer FA, Barber BH. Sequence and peptide-binding motif
for a variant of HLA-A*0214 (A*02142) in an HIV-1 resistant individual from the Nairobi sex worker
cohort. Immunogenetics 2001;53:10-4.
Mabey D, Peeling R.W. Rapid diagnostics tests for sexually transmitted infections. International Planned
Parenthood Federation (IPPF) Medical Bulletin 36:1-3, 2002.
Mabey D, Peeling RW, Perkins MD. Rapid and simple point of care diagnostics for STIs. Sex Transm
Infect 77:397-398, 2001.
Mabey D, Peeling RW, Ustianowski A, Perkins M. Diagnostics for the developing world. Nature Reviews
Microbiology 2: 231-40, 2004.
Mabey D, Peeling RW. Lymphogranuloma venereum. Sex Transm Inf 78:90-2, 2002.
MacDonald K, Embree JE, Nagelkerke NJD, Castillo J, Ramdahin S, Njenga S, Oyugi J, Ndinya-Achola J,
Barber BH, Bwayo JJ, Plummer FA. HLA A2/6802 Supertype is associated with reduced risk of perinatal
HIV-1 transmission. J Infect Dis 183:503-506, 2001.
MacDonald K, Matukas L, Embree JE, Fowke K, Kimani J, Nagelkerke NJD, Oyugi J, Kiama P, Kaul R,
Luscher MA, Rowland-Jones S, Ndinya-Achola J, Ngugi E, Bwayo JJ, Plummer FA. Human leukocyte antigen
supertypes and immune susceptibility to HIV-1, implications for vaccine design. Immunology Letters 79:151157, 2001.
MacDonald KS, Embree JE, Nagelkerke NJ, Castillo J, Ramdahin S, Njenga S, Oyugi J, Ndinya-Achola J,
Barber BH, Bwayo JJ, Plummer FA. The HLA A2/6802 supertype is associated with reduced risk of perinatal
human immunodeficiency virus type 1 transmission. J Infect Dis 2001;183:503-6.
MacDonald KS, Malonza I, Chen DK, Nagelkerke NJD, Nasio JM, Ndinya-Achola J, Bwayo JJ, Sitar DS,
Aoki FY, Plummer FA. Vitamin A and risk of HIV-1 seroconversion among Kenyan men with genital
ulcers. AIDS 2001: 15:635-639.
Macey, J., A. Johnston, L. Elliott, D. Krahn, D. Nowicki, J. Wylie. 2002. Outbreak of diarrhoeal illness in
attendees at a Ukrainain dance festival, Dauphin, Manitoba - May, 2001. Can. Commun. Dis. Report.
28:141-145.
Magro CM, Crowson N, Dawood M and Nuovo GJ. (2002). Parvoviral infection of endothelial cells with
concomitant TNF expression-possible role in vasculitis and autoimmune disease. J Rheumatol. 29: 12271235.
Markowsky MJ, Smith KK, Ariano RE, Zhanel GG, Gin AS. An assessment of vancomycin use in 2 tertiary
care hospitals. Canadian Journal of Hospital Pharmacy 2004;57:150-157.
Marra MA, Jones SJ, Astell CR, Holt RA, Brooks-Wilson A, Butterfield YS, Khattra J, Asano JK, Barber SA,
Chan SY, Cloutier A, Coughlin SM, Freeman D, Girn N, Griffith OL, Leach SR, Mayo M, McDonald H,
Montgomery SB, Pandoh PK, Petrescu AS, Robertson AG, Schein JE, Siddiqui A, Smailus DE, Stott JM,
Yang GS, Plummer F, Andonov A, Artsob H, Bastien N, Bernard K, Booth TF, Bowness D, Czub M,
Drebot M, Fernando L, Flick R, Garbutt M, Gray M, Grolla A, Jones S, Feldmann H, Meyers A, Kabani
A, Li Y, Normand S, Stroher U, Tipples GA, Tyler S, Vogrig R, Ward D, Watson B, Brunham RC,
Krajden M, Petric M, Skowronski DM, Upton C, Roper RL. (2003). The Genome sequence of the SARSassociated coronavirus. Science. 300(5624):1399-404.
Marrie TJ, DeCarolis E, Yu VL, Stout J, Canadian Community-Acquired Pneumonia Investigators (L.
Nicolle, member). Legionnaires Disease – Results of a multicentre Canadian study. Can Jour Infect Dis
2003; 14:154-158.
Marrie TJ, Peeling RW, Reid T, DeCarolis E, Canadian Community-acquired Pneumonia Investigators (L.
Nicolle, member). Chlamydia species as a cause of community-acquired pneumonia in Canada. Eur
Respir Jour 2003; 21:779-785.
Marshall, A.J., Du, Q., Draves, K.E., Shikishima, Y., HayGlass, K.T. and Clark, E.A. FDC-SP, a novel
secreted protein expressed by follicular dendritic cells. J. Immunol. 169: 2381-2389. 2002.
Mayne M, Moffatt T, Kong H, McLaren PJ, Fowke KR, Becker KG, Namaka M, Schenck A, Bardoni B,
Bernstein CN, Melanson M CYFIP2 is highly abundant in CD4+ cells from multiple sclerosis patients and is
involved in T cell adhesion. European Journal of Immunology 2004 34:1217-27.
Mazzulli T, Skulnick M, Small G, Marshall W, Hoban DJ, Zhanel GG, Finn S, Low DE. Susceptibility of
community gram-negative urinary tract isolates to mecillinam and other oral agents. Canadian Journal of
Infectious Diseases, 2001;12(5):289-292.
Mbugua F, F Okoth, M Gray, T Kamau, A Kalu, R Eggers, P Borus, J Kombich, A Langat, P Maritim, J
Lesiamon and GA Tipples. Molecular epidemiology of measles virus in Kenya. J Med Virol 71:599-604
(2003).
McLaren PJ, Mayne M, Rosser S, Moffatt T, Becker KG, Plummer FA, Fowke KR. Antigen-specific gene
expression profiles of peripheral blood mononuclear cells do not reflect those of T-lymphocyte subsets.
Clin Diagn Lab Immunol. 2004 Sep;11(5):977-82.
Mehta A, B Conyers, DLJ Tyrrell, KA Walters, GA Tipples, RA Dwek, TM Block. Structure activity
relationship of a new class of anti-hepatitis B virus agents. Antimicrob Agents Chemother 46:4004-6
(2002).
Melito, P. L., Munro, C., Chipman, P. R., Woodward, D. L., Booth, T.F. and Rodgers, F. G. (2001).
Helicobacter winghamensis sp. nov., a novel Helicobacter sp. isolated from patients with gastroenteritis..
J Clin Microbiol. 39: 2412-7.
Mellmann A., J. L. Cloud, S. Andrees, K. Blackwood, K. C. Carroll, A. Kabani, A. Roth, D. Harmsen.
2003. Evaluation of RIDOM, MicroSeq, and GenBank services for molecular identification of Nocardia
species. Int J Med Microbiol. 293(5):359-70.
Mendez, I., Y.-M. She, W. Ens, and K.M. Coombs. (2003). Structure of the reovirus outer capsid and
kinetics of its digestion as determined by mass spectrometry. Virology 311:289-304.
Menec VH, MacWilliam LM, Aoki, FY. Hospitalizations and deaths due to respiratory illness during
influenza season: a comparison of community residents, senior housing residents, and nursing home
residents. J Gerontol A Biol Sci Med 2002; 5:926-635.
Metge CJ, Blanchard JF, Peterson S, Bernstein CN. Use of pharmaceuticals by inflammatory bowel
disease patients: a population-based study. Am J Gastroenterol 2001;96:3348-55.
Meunier D., D. Boyd, M.R. Mulvey, S. Baucheron, C. Mammina, A. Nastasi, E. Chaslus-Dancla, and A
Cloeckaert. 2002 Salmonella enterica Serovar Typhimurium DT104 antibiotic resistance Genomic Island I
in S. enterica Serovar Paratyphi B. Emerging Infectious Diseases. 8:430-433.
Mikelova LK, Halperin SA, Scheifele D, Smith B, Ford-Jones E, Vaudry W, Jadavji T, Law B, Moore D and
members of IMPACT. Predictors of mortality in infants hospitalized with pertussis: a case control study of
16 pertussis deaths in Canada. J Pediatrics, 2003; 143:576-81.
Miller M, Gravel D, Paton S. the CANADIAN HOSPITAL EPIDEMIOLOGY COMMITTEE (MULVEY M,
EMBIL J AND EMBREE JE, MEMBERS) and the Canadian Nosocomial Infection Surveillance Program,
Health Canada.
Reuse of Single-Use Medical Devices in Canadian Acute-Care Healthcare Facilities
2001. Can Commun Dis Rep.; 27(23), 2001
Miller MA, Hyland M, Ofner-Agostini M, Gourdeau M, Ishak M, the CANADIAN HOSPITAL EPIDEMIOLOGY
COMMITTEE (MULVEY M, EMBIL J AND EMBREE JE, MEMBERS) and the Canadian Nosocomial
Infection Surveillance Program, Health Canada. Morbidity, mortality, and health-care burden of
nosocomial Clostridium difficile-associated diarrhea in Canadian hospitals. Infect Control Hosp Epidemiol;
23(3): 137-40, 2002.
Mink SN, Jacobs H, Bose D, Duke K, Cheng Z, Liu G, Light RB. N,N’,N’’ triacetylglucosamine, an inhibitor
of lysozyme, prevents myocardial depression in E. coli sepsis in dogs. Critical Care Med 32:184-93, 2004.
Mink SN, Jacobs H, Bose D, Duke K, Cheng Z-Q, Liu G, Light RB. Lysozyme: a mediator of myocardial
depression and adrenergic dysfunction in septic shock in dogs. J Mol Cell Cardiol 35:265-275, 2003.
Minuk GY, Zhang M, Wong S, Uhanova J, Bernstein CN, Dawood MR and Giulvi A (2003). Vairal
Hepatitis in A Canadian First Nations Community. Can. J. Gastroentrology 17: 593-596.
Mirsattari S, Johnston JB, McKenna R, Del Bigio M, Orr P, Ross RT, Power C. Aboriginals with Multiple
Sclerosis: HLA types and predominance of neuromyelitis optica. Neurology 2001;56:317-23.
Moore D, LeSaux N, Schieffle D, Halperin S, IMPACT (J. EMBREE, CPS SCIENTIFIC LIAISON). Lack of
evidence of encephalopathy related to pertussis vaccine: Active surveillance by IMPACT, Canada 1993-2002.
Pediatr Infect Dis J 23:568-571, 2004.
Mora-Duarte J, Betts R, Rotstein C, Colombo AL, Thompson-Moya L, Smietana J, Lupinacci R, Sable C,
Kartsonis N, Perfect J and The Caspofungin Invasive Candidiasis Study Group (G. Harding – member).
Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis. N Engl J Med. 2002:347(25):
2020-28.
Morris CN, Overview of Workplace Programs in Malawi, ILAB US Dept of Labour Circular, Jan 2002.
Morris CN, Workplace programs in Malawi: a case study. AIDS Analysis Africa, July, 2003.
Morris PE, Light RB, Garber GE. Identifying patients with severe sepsis who should not be treated with
drotrecogin alfa (activated). Am J Surg 184:519-524, 2002.
Morris, CN, et al, A package of care for HIV/AIDS in the occupational setting in South Africa: a pilot
project, AIDS Patient Care and STDs, 12(15) Dec 2001, p.633-640.
Moses S, Ngugi EN, Costigan A, Kariuki C, Maclean I, Brunham RC, Plummer FA. Response of a
sexually transmitted infection epidemic to a treatment and prevention program in Nairobi, Kenya. Sex
Transm Infect 2002; 78(Suppl 1):i114-i120.
Mouland, A.J., M. Coady, Yao X-J, E.A. Cohen. 2002. Hypophosphorylation of poly(a) polymerase and
increased polyadenylation activity are associated with human immunodeficiency virus type 1 Vpr
expression. Virology. 292: 321-30.
Mulvey MR, L. Chui, J. Ismail, L. Louie, C. Murphy, N. Chang, M. Alfa, and Canadian Committee for the
Standardization of Molecular Methods. 2001. Development of a Canadian Standardized Protocol for
Subtyping Methicillin-Resistant Staphylococcus aureus Using Pulsed-Field Gel Electrophoresis. Journal of
Clinical Microbiology. 39:3481-3485.
Mulvey, M.R., D. Boyd, A. Cloeckaert, R. Ahmed and Lai-King Ng, and the Canadian Public Health
Laboratories. 2004. A dramatic increase of Salmonella enterica Serovar Paratyphi B dT+ harboring the
antibiotic resistant Salmonella Genomic Island 1 in Canada in 2001-2002. Emerging Infectious Diseases.
10:1307-1310.
Mulvey, M.R., D.A. Boyd, L. Baker, O. Mykytczuk, E.M. Reis, M.D. Asensi, D.P. Rodrigues, L.K. Ng.
2004. Characterization of a Salmonella enterica serovar Agona strain harbouring a class 1 integron
containing novel OXA-type {beta}-lactamase (blaOXA-53) and 6'-N-aminoglycoside acetyltransferase
genes [aac(6')-I30]. J. Antimicrob.Chemother. 54: 354-59.
Mulvey, M.R., G. Soule, D. Boyd, W. Demczuk, R. Ahmed, and the Multi-provincial Salmonella
Typhimurium Case Control Study Group. 2003. Characterization of the First Extended-Spectrum BetaLactamase Producing Salmonella Isolated in Canada. Journal of Clinical Microbiology 41:460-462.
Mulvey, M.R., D. Boyd, L-K. Ng, S. Brown, M. Lombos, B. Ciebin, A. Li, and F. Jamieson. 2004.
Characterization of the first Salmonella enterica serovar Typhi harbouring an integron in Canada.
Antimicrobial Agents and Chemotherapy. 48:689-690.
Mulvey, M.R., E. Bryce, D. Boyd, M. Ofner-Agostini, S. Christianson, A. E. Simor, S. Paton, The Canadian
Hospital Epidemiology Committee, and The Canadian Nosocomial Infection Surveillance Program, Health
Canada. 2004. Ambler class A extended-spectrum beta-lactamase-producing Escherichia coli and
Klebsiella spp. in Canadian hospitals. Antimicrobial Agents and Chemotherapy. 48:1204-1214.
Munger KL, DeLorenze GN, Levin LI, Rubertone MV, Vogelman JH, Peck CA, Peeling RW, Orentreich N,
Ascherio A. A prospective study of Chlamydia pneumoniae infection and risk of MS in two US cohorts.
Neurology 62:1799-1803, 2004.
Munger KL, Peeling RW, Hernan MA, Chasan-Taber L, Olek MJ, Hankinson SE, Hunter D, Ascherio A.
Infection with Chlamydia pneumoniae and risk of multiple sclerosis. Epidemiology. 14:141-7, 2003.
Nagai MK, Embil JM. Becaplermin: Recombinant Platelet-derived Growth Factor, A New Treatment for
Healing Diabetic Foot Ulcers. Expert Opin Biol Ther 2002; 2: 211-8.
Nagelkerke N.J.D et al. Incidence of subclinical infection with Legionella Pneumonia at an outbreak in
the Netherlands. Statistics in Medicine 2003. 22(24):3713-24.
Nagelkerke N.J.D et al. Logisitic discrimination of mixtures of M.tuberculosis and non-specific tuberculin
reactions”. Statistics in Medicine. 2001 Apr 15;20(7):1113-24..
Nagelkerke N.J.D et al. Validation of parasite transmission models: the example of onchocerciais. Neth.
J. Med. 2002, Suppl Aug 2002. 60:44-51.
Nagelkerke N.J.D. Estimation of the basic reproduction number for infectious diseases from agestratified serological survey data – Discussion. Applied-Statistics. 2001; 50 Part 3 : 283-292.
Nagelkerke N.J.D. et al. The design and analysis of studies on density dependent mechanisms in
infection dynamics. Bulletin ISI 2003, proceedings ISI conference Berlin.
Nagelkerke NJD , DeVlas SJ. The epidemiological impact of an HIV vaccine on the HIV?AIDS epidemic
in southern India. World Bank working papers. 2003.
Nagelkerke NJD, Jha P, de Vlas SJ, Korenromp EL, Moses S, Blanchard JF, Plummer FA. Modelling
the HIV epidemics in India and Botswana: The impact of interventions to prevent transmission. Bull
WHO 2002;80(2):89-96.
Nash D, Mostashari F, Fine A, Miller J, O’Leary D, Murray K, Huang A, Rosenberg A, Greenberg A,
Sherman M, Wong S, Campbell GL, Roehrig J, Gubler DJ, Shieh WJ, Zaki S, Smith P, Layton M and the
1999 West Nile Outbreak Response working group ( includes H Artsob). 2001. The outbreak of West
Nile virus infection in the New York City area in 1999. New England Journal of Medicine 344:1807-1814.
NATIONAL ADVISORY COMMITTEE ON IMMUNIZATION (ORR P, EMBREE JE, MEMBERS). Update on
Hepatitis A vaccine (Avaxim, Aventis Pasteur). Canada Communicable Dis Report 27 (ACS-5):1-2, October
15, 2001.
NATIONAL ADVISORY COMMITTEE ON IMMUNIZATION (ORR P, EMBREE JE, MEMBERS). Statement on
recommended use of meningococcal vaccines. Canada Communicable Dis Report 27 (ACS-6):2-36,
October 15, 2001.
NATIONAL ADVISORY COMMITTEE ON IMMUNIZATION (ORR P, EMBREE JE, MEMBERS).. P. Orr,
primary author, Supplementary statement for the 2001-2002 season: Influenza vaccination of persons
who experienced oculo-respiratory syndrome following previous influenza vaccination. Canada
Communicable Dis Report 27 (ACS-7):1-7, November 15, 2001.
NATIONAL ADVISORY COMMITTEE ON IMMUNIZATION (ORR P, EMBREE JE, MEMBERS). Statement on
Smallpox vaccination. Canada Communicable Dis Report 28 (ACS-1):1-12, January 15, 2002.
NATIONAL ADVISORY COMMITTEE ON IMMUNIZATION (ORR P, EMBREE JE, MEMBERS). Statement on
the recommended use of pneumococcal conjugate vaccine. Canada Communicable Dis Report 28 (ACS2):1-27, January 15, 2002.
NATIONAL ADVISORY COMMITTEE ON IMMUNIZATION (ORR P, EMBREE JE, MEMBERS). NACI update
to statement on varicella vaccine. Canada Communicable Dis Report 28 (ACS-3):1-7, February 15, 2002.
NATIONAL ADVISORY COMMITTEE ON IMMUNIZATION (ORR P, EMBREE JE, MEMBERS). P ORR,
PRIMARY AUTHOR. Statement on influenza vaccination for the 2002-2003 season. Canada Communicable
Dis Report 28 (ACS-5):1-20, August 1, 2002.
NATIONAL ADVISORY COMMITTEE ON IMMUNIZATION (ORR P, EMBREE JE, MEMBERS). P. ORR,
PRIMARY AUTHOR. Supplementary statement for the 2002-2003 influenza season: Update on oculorespiratory syndrome in association with influenza vaccination. Canada Communicable Dis Report 28
(ACS-6):1-8, September 1, 2002.
NATIONAL ADVISORY COMMITTEE ON IMMUNIZATION (ORR P, EMBREE JE, MEMBERS). Statement on
influenza vaccination for the 2003-2004 season. Canada Communicable Dis Report 29 (ACS-4):1-20,
August 15, 2003.
NATIONAL ADVISORY COMMITTEE ON IMMUNIZATION (ORR P, EMBREE JE, MEMBERS).. Prevention
of pertussis in adolescents and adults. Canada Communicable Dis Report 29 (ACS-5):1-9, September 1,
2003.
NATIONAL ADVISORY COMMITTEE ON IMMUNIZATION (ORR P, EMBREE JE, MEMBERS).
Supplementary statement on conjugate meningococcal vaccines. Canada Communicable Dis Report 29
(ACS-6):10-11, September 1, 2003.
NATIONAL ADVISORY COMMITTEE ON IMMUNIZATION (ORR P, EMBREE JE, MEMBERS). Prepared by
J. Embree. Statement on the recommended use of monoclonal anti-RSV antibody (Palivizumab). Canada
Communicable Dis Report 29 (ACS-7):1-13, September 15, 2003.
NATIONAL ADVISORY COMMITTEE ON IMMUNIZATION (ORR P, EMBREE JE, MEMBERS). PREPARED
BY EMBREE JE, Statement on the recommended use of pneumococcal conjugate vaccination:
addendum. Canada Communicable Dis Report 29 (ACS-8):14-15, September 15, 2003.
NATIONAL ADVISORY COMMITTEE ON IMMUNIZATION (ORR P, EMBREE JE, MEMBERS). P ORR,
PRIMARY AUTHOR. Statement on influenza vaccination for the 2004-2005 season. Canada Communicable
Dis Report 30 (ACS-3):1-32, June 15, 2004.
Neumann G, Feldmann H, Watanabe S, Lukashevich I, Kawaoka Y (2002). Generation of Ebola virus
entirely from cloned cDNA: new opportunities in experimental filovirus research. J. Virol. 76: 406-410.
Ng, L.-K., I. Martin, A. Lau, and The National Gonococcal Surveillance Program Members. 2003. Trends
of chromosomally mediated antimicrobial resistance in Neisseria gonorrhoeae in Canada: 1994-1999. Sex.
Transm. Dis. 30:896-900.
Ng, L.-K., I. Martin, G. Liu, and L. Bryden. 2002. Mutation in 23S rRNA associated with macrolide
resistance in Neisseria gonorrhoeae Antimicrob. Agents Chemother. 46:3020-3025.
Ng, L.-K., P. Sawatzky, I. Martin, and S. Booth. 2002. Characterization of Ciprofloxacin Resistance in
Neisseria gonorrhoeae Isolates in Canada. Sexually Transm. Dis. 29:780-8.
Ng, L.-K., P. Sawatzky, M. Galas, DP. Rodrigues, I. Heitmann, S. Fernandez, A. Bolmström. 2003. Can
Etest be used to determine Vibrio cholerae susceptibility to erythromycin? Antimicrob. Agents Chemother.
47:1479-80.
Ng, L-K, I. Martin, M. Alfa, M. Mulvey. Multiplex PCR for the Detection of Tetracycline Resistant
Genes. Molecular Cellular Probes 2001;15:209-215.
Nichol K, Zhanel GG and Hoban DJ. Characterization of penicillin-binding protein 1A, 1B and 2X
mutations in Canadian isolates of penicillin-resistant Streptococcus pneumoniae. Antimicrobial Agents and
Chemotherapy 2002;46(10):3261-3264.
Nichol KA, Zhanel GG, Hoban DJ. Molecular epidemiology of penicillin-resistant and ciprofloxacinresistant Streptococcus pneumoniae in Canada. Antimicrobial Agents and Chemotherapy,
2003;47(2):804-808.
Nicolle LE, Gutkin A, Smart G., Dawood M, Van Caeseele P, Giulivi A and Minuk M (2004). Serologic
studies of West Nile Virus in a liver transplant population. Can J Infect Dis Med Micro 15(5): 271 – 274.
Nicolle LE, Harding GKM, Zhanel GG. Treatment of asymptomatic bacteriuria in diabetic women.
(Letter) New Engl Jour Med 2003; 348:957-958.
Nicolle LE. Best pharmacological practices: urinary tract infections. Expert Opinion on
Pharmacotherapy 2003; 4:693-704.
Nicolle, L.E. A practical approach to the management of complicated urinary tract infection. Drugs and
Aging 2001; 18:243-254.
Nicolle, L.E. Empiric treatment of acute cystitis in women. Internat Jour Antimicrobial Agents 2003;
22:1-6.
Nicolle, L.E. Management of urinary tract infection in the elderly. Home Health Care Consultant 2001;
8:10-20.
Nicolle, L.E. Resistant pathogens in urinary tract infections. Jour Amer Ger Soc 2002; 50 (7 Suppl):
230-235.
Nicolle, L.E. The chronic indwelling catheter and urinary infection in long term care facility residents.
Infect Control Hosp Epidemiol 2001; 22:316-321.
Nicolle, L.E. To treat or not to treat: managing bacteriuria in elderly people (letter) Can Med Assoc
Jour 2001; 164: 620.
Nicolle, L.E. Urinary tract infection: Traditional pharmacologic therapies. Amer Jour Med 2002,
113(1A): 35S-44S.
Nicolle, L.E. Urinary tract pathogens in complicated urinary infection and in the elderly. Jour Infect Dis
2001, 183 (Suppl 1): S5-S8.
Nicolle, L.E. (letter). Asymptomatic bacteriuria in institutionalized elderly in Israel. Jour Amer Medical
Directors Assoc; 2002; 3: .
Nicolle, L.E., Madsen, K.S., KeBeeck, G.D., Blochlinger, E., Borrild, N., Bru, J.P., McKinnon, C.,
O’Doherty, B., Spiegel, W., van Ballen, F.A.M., Menday, P. Three days pivmecillinam or norfloxacin for
treatment of acute uncomplicated urinary infection in women. Scand Jour Infect Dis 2002; 34:487-492.
Noreddin A, Laing N, Nichol K, Roberts D, Bellyou T, Wierzbowski A, Hoban DJ and Zhanel GG.
Pharmacodynamic modelling of clarithromycin against macrolide-resistant (PCR positive mefA or ermB)
Streptococcus pneumoniae simulating clinically achievable free drug serum and epithelial lining fluid (ELF)
concentrations. Antimicrobial Agents and Chemotherapy 2002;46(12):4029-34.
O’Hara, D., M. Patrick, D. Cepica, K.M. Coombs, and R. Duncan. (2001). Avian reovirus major mu-class
outer capsid protein influences efficiency of productive macrophage infection in a virus strain-specific
manner. J. Virol. 75:5027-5035.
Obasi A,. Balira R, Todd J, Ross D, Changalucha J, Mosha F, Grosskurth H, Peeling R, Mabey D, Hayes
R. Prevalence of HIV and Chlamydia in 15-19 year olds in rural Mwanza. Trop. Med. Int. Health 6:51725, 2001.
Oh PI, Lanctot KL, Yoon A et al including the COMPOSS Investigators (B. Law, investigator).
Palivizumab prophylaxis for respiratory syncytial virus in Canada: utilization and outcomes. Pediatr Infect
Dis J 2002(Jun); 21:512-8.
Olberg RA, Barker IK, Crawshaw GJ, Bertelsen MF, Drebot MA, Andonova M. (2004) West Nile virus
encephalitis in a Barbary macaque (Macaca sylvanus). Emerg Infect Dis. 10(4):712-4.
Orr, P. H., R. Brown, S. MacDonald and D. G. Milley. 2001. Brochiolitis in Inuit Children from a
Canadian Central Arctic Community, 1995 – 1996. International Journal of Circumpolar Health 60:649658
Owusu-Asiedu A, C.M. Nyachoti, S.K. Baidoo, R.R. Marquardt and Xi Yang. Response of early-weaned
pigs to an enterotoxigenic Escherichia coli (K88) challenge when fed diets containing spray-dried porcine
plasma or pea protein isolate plus egg yolk antibody. J. Animal Sci. 81:1781-9, 2003.
Pasick J, Weingartl H, Clavijo A, Riva J, Kehler H, Handel K, Watkins E, and Hills K (2003)
Characterization of Avian Influenza Virus Isolates Submitted to the National Centre for Foreign Animal
Disease Between 1997 and 2001. Avian Dis 47: 1208 - 1213
Patrick, M., R. Duncan, and K.M. Coombs. (2001). Generation and genetic characterization of avian
reovirus temperature-sensitive mutants. Virology 284:113-122.
Pauls, R. J., C. Y. Turenne, J. N. Wolfe, and A. Kabani. A High Proportion of Novel Mycobacteria Species
Identified by 16S rDNA Analysis Among Slowly Growing AccuProbe Negative Strains in a Clinical Setting.
Am. J. Clin. Pathol. 120(4): 560-566.
Peeling RW, Mabey D, Disease Watch: Syphilis. Nature Reviews Microbiology 2: 2004.
Peeling RW, Ye H. Diagnostic tools for preventing and managing maternal and congenital syphilis: an
overview. Bulletin of WHO 82:439-446, 2004.
Peeling RW. Rapid diagnostic tests for sexually transmitted infections. Chinese Journal of Dermatology.
2003
Peng, Z., Wang, H., Mao, X., HayGlass, K.T., Simons, F.E.R. CpG oligodeoxynucleic vaccination
suppresses IgE induction but may fail to downregulate ongoing IgE responses in mice. International
Immunology. 13:3-11. 2001.
Pepperell C, Rau N, Krajden S, Kern R, Humar A, Mederski B, Simor A, Low DE, McGeer A, Mazzulli,
Burton J, Jaigobin C, Fearon M, Artsob H, Drebot MA, Halliday W, Brunton J. (2003). West Nile virus
infection in 2002: Morbidity and mortality among patients admitted to hospital in southcentral Ontario.
CMAJ 168:1399-1405.
Peret, T.C., Boivin, G., Li, Y., Couillard, M., Humphrey, C., Osterhaus, A.D., Edman, D.D., and Anderson,
L.J. (2002). Characterization of human metapneumovirus isolated in North America. J. Infect. Dis. 185:
1660-1663.
Petit G, De Wals P, Law B, Tam T, Erickson LJ, Guay M, Framarin A. Epidemiological and economic
burden of pneumococcal diseases in Canadian children. Can J Infect Dis 2003;14(4):215-220.
Petrelli D., M. Kaushal Sharma, J. Wolfe, A. Al-Azem, E. Hershfield and A. Kabani (2004). Strainrelated virulence of the dominant Mycobacterium tuberculosis strain in the Canadian province of
Manitoba. Tuberculosis, 84(5):317-26.
Pitout, J. D. D., M. D. Reisbig, M. Mulvey, L. Chui, M. Louie, L. Crowe, D. L. Church, S. Elsayed, D.
Gregson, R. Ahmed, P. Tilley and N. D. Hanson. 2003.. Association between the Handling of Pet Treats
and Infection with Salmonella enterica serotype Newport expressing the AmpC -lactamase, CMY-2.
Journal of Clinical Microbiology. 41:4578-4582.
Plouffe JF, Breiman RF, Fields BS, Herbert M, Inverso J, Knirsch C, Kolokathis A, Marrie TJ, Nicolle L,
Schartz DB. Azithromycin in the treatment of Legionella pneumonia requiring hospitalization. Clin Infect
Dis 2003; 1475-1480.
Plourde, P.J., Travellers’ Diarrhea in Children, Paediatrics and Child Health 2003;8(2):99-103.
Poutanen SM, Low DE, Henry B, Finkelstein S, Rose D, Green K, Tellier R, Draker R, Adachi D, Ayers M,
Chan AK, Skowronski DM, Salit I, Simor AE, Slutsky AS, Doyle PW, Krajden M, Petric M, Brunham RC,
McGeer AJ and the National Microbiology Laboratory Canada (includes H Artsob) and the Canadian SARS
study team.2003. Identification of severe acute respiratory syndrome in Canada. New Eng J Med
348:1995-2005.
Prabhat Jha P, Nagelkerke NJD, Ngugi EN, Prasada Rao JVR, Willbond B, Moses S , Plummer FA.
Interventions To Reduce HIV Transmission In Developing Countries: The Lessons Of Two Decades Of
AIDS. Science 2001;292:224-5.
Qiu H, J. Yang, H. Bai, Y. Fan, S. Wang, Xiaobing Han, L. Chen and X. Yang. Less inhibition of
interferon-r to organism growth in host cells may contribute to the high susceptibility of C3H mice to
Chlamydia trachomatis lung infection. Immunology, 111:453-461, 2004
Rassoulian Barrett S.L. , Cookson, B.T., Carlson, L.C. Bernard, K. A. and Coyle M.B. 2001. Diversity
within Reference Strains of Corynebacterium matruchotii Includes Corynebacterium durum and a Novel
Organism. Journal of Clinical Microbiology 39: 943-948
Raz, R., Gronich D, Ben-Israel, Y., Nicolle, L. Asymptomatic bacteriuria in institutionalized elders in
Israel. Jour Amer Medical Directors Assoc 2001; 2:275-278.
Read, T.D., Meyers, G.S.A., Nelson, W.C., Paulsen, I.T., McClarty, G., Hsia, R., Brunham, R.C., Rank,
R.G., Bavoil, P.M and Fraser, C.M. 2003. Genome Sequence of Chlamydiophilia caviae (Chlamydia psittaci)
GPIC: Biotype Specific Genes in the Evolution of the Chlamydiaceae. Nucleic Acid Res. 31:2134-47.
Rex J.H., Walsh T.J., Nettleman M., Anaissie E.J., Bennett J.E., Bow E.J., Carillo-Munoz A.J., Chavanet
P., Cloud G.A., Denning D.W., de Pauw B.E., Edwards Jr., J.E., Hiemenz J.W., Kauffman C.A., LopezBerestein G., Martino P., Sobel J.D., Stevens D.A., Slyvester R., Tollemar J., Viscoli C., Viviani M.A., Wu
T.: Need for Alternative Trial Designs and Evaluation Strategies for Therapeutic Studies of Invasive
Mycoses. Clin Infect Dis 2001;33:95-196.
Romanowski B, The Valtrex HS230017 Study Group (FY. Aoki and P. Orr, members), Marina RB,
Roberts JN. Patients’ preference of Valacyclovir once-daily suppressive therapy versus twice-daily episodic
therapy for recurrent genital herpes. A randomised study. Sexually Trans Dis 2003; 30:226-231.
Ronald A. The Etiology of Urinary Tract Infection: Traditional and Emerging Pathogens. Amer J Med.
2002 July 8:113(Suppl 1A).
Ronald, A.R., Nicolle, L.E., Stamm, W.E., Krieger, J., Warren, J., Schaeffer, A., Naber, K.G., Hooton,
T.M., Johnson, J., Chambers, S., Andriole, V. Urinary tract infection in adults: Research priorities and
strategies. Internal J Antimicrob Agents 2001; 17:343-348.
Rose G, Ross LL, Palatnick W, Embil JM. Photoquiz: Envenimation – Spider Bite. Clin Infect Dis, 2001;
595,636-37.
Rowland-Jones SL, Pinheiro S, Kaul R, Hansasuta P, Gillespie G, Dong T, Plummer FA, Bwayo JJ, Fidler
S, Weber J, McMichael A, Appay V. How important is the “quality” of the cytotoxic T lymphocyte (CTL)
response in protection against HIV infection? Immunol Lett 2001;79:29-36.
Safronetz D, A Humar and GA Tipples. Differentiation and quantification of human herpesvirus 6A, 6B
and 7 by real-time PCR. J Virol Methods 112:99-105 (2003).
Safronetz D, M Petric, R Tellier, B Parvez and GA Tipples. Mapping ganciclovir resistance in human
herpesvirus 6 U69 protein kinase. J Med Virol 71:434-9 (2003).
Saginur, R., Nixon, J., Devries, B., Bruce, N., Carruthers, C., Scully, L., Berger, R., Leech, J., Nicolle, L.,
Mackenzie, A. Transmission of hepatitis C in a pharmacologic study. Infect Control Hosp Epidemiol
2001; 22:697-700.
Sande MA, Ronald AR. Update in infectious diseases. Ann Intern Med. 2004 Feb 17;140(4):290-5.
Sanders EJ et al (Nagelkerke NJD). Mortality impact of AIDS in Addis Ababa, Ethiopia. AIDS 2003; 17:
1209-16.
Sanders EJ et al (Nagelkerke NJD). Mortality impact of AIDS in Addis Ababa, Ethiopia. Ethiop Med J.
2003 Jun;41 Suppl 1:35-42.
Sarwal, S., L.-K. Ng, C. Sevigny, and T. Wong. 2003. Increasing incidence of ciprofloxacin-resistance
Neisseria gonorrhoeae infection in Canada. Can. Med Assoc. J. 168:872-3.
Schachter J, Stephens RS, Timms P, Kuo C, Bavoil PM, Birkelund S, Boman J, Caldwell H, Campbell LA,
Chernesky M, Christiansen G, Clarke IN, Gaydos C, Grayston JT, Hackstadt T, Hsia R, Kaltenboeck B,
Leinonnen M, Ocjius D, McClarty G, Orfila J, Peeling R, Puolakkainen M, Quinn TC, Rank RG, Raulston
J, Ridgeway GL, Saikku P, Stamm WE, Taylor-Robinson DT, Wang SP, Wyrick PB. Radical changes to
chlamydia taxonomy not necessary just yet: Int. J Syst Evol Microbiol 51:249, 251-3, 2001.
Scheifele D, Halperin S, Pelletier L, Talbot J, Lovgren M, Vaudry W, Jadavji T, Law B, MacDonald N, Gold
R, Wang E, Mills E, Lebel M, Dery P, Morris R. Reduced susceptibility to penicillin among pneumococci
causing invasive infection in children - Canada, 1991-1998. Canadian Journal of Infectious Diseases 2001;
12:241-6.
Scheifele D, Halperin S, Vaudry W, Jadavji T, Tan B, Law B, LeSaux N, Ford-Jones L, Lebel M, Moore D,
Dery P, Morris R, Waters J, Embree J, Wallop W. Historic low Haemophilus influenzae type B case tally –
Canada 2000. Can Commun Dis Rep 15:149-150, 2001.
Scheifele DW, Halperin SA, Gold R, Samson H, King A and Members of IMPACT (B. Law, IMPACT
Winnipeg site investigator) . Assuring vaccine safety: a celebration of 10 years of progress with the
IMPACT project. Paediatrics and Child Health, 2002; 7:648-8.
Schnittler HJ, Feldmann H (2003) Viral hemorrhagic fever – a vascular disease. Thromb. Haemost. 89:
967-972.
Scotter SL. et al (Nagelkerke NJD). Validation of ISO method 11290 part 2. Enumeration of Listeria
monocytogenes in foods. Int J Food Microbiol. 2001 Oct 22;70(1-2):121-9.
Sejvar J, Bancroft E, Winthrop K, Bettinger J, Bajani M, Bragg S, Shutt K, Kaiser R, Marano N, Popovic T,
Tappero J, Ashford D, Mascola L, Vugia D, Perkins B, Rosenstein N and the Eco-Challenge Investigation
Team (includes H Artsob). 2003. Leptospirosis in “Ecochallenge” athletes, Malaysian Borneo, 2000.
Emerging Infect Dis 9:702-07.
Severini A, C Sevenhuysen, M Garbutt, and G Tipples. Structure of replicating intermediates of human
herpesvirus type 6. Virology 314:443-50 (2003).
Shang H, Chen X, Ye QH, Wang Y, Xu WY, Peeling RW, Mabey D. Pelvic Inflammatory Disease in the
Peoples’ Republic of China: Aetiology and Management. Int J STD & AIDS. 13:568-72, 2002.
Sharma M. K., Al-Azem A, Wolfe J, Hershfield E and A. Kabani. 2003. Identification of a predominant
isolate of Mycobacterium tuberculosis using molecular and clinical epidemiology tools and in vitro cytokine
responses. BMC - Infectious Diseases 3: 3.
Sharma S, Harding GKM. Necrotizing lung infection caused by the protozoan Balantidium coli. Can J
Infect Dis. 2003;14(3):163-166.
Shaw, W.W., Xu, X., Li, Y., Normand, S., Uyeki, R., Kunimoto, G., Hall, H., Klimov, A., Cox, N.J., and
Subbarao, K. (2002). Reappearance and global spread of variants of influenza B/Victoria/2/87 lineage
viruses in the 2000-2001 and 2001 –2002 seasons. Virology. 303: 1-8.
Shukla, S., K., K. A. Bernard, M. Harney, D. N. Frank, and K. D. Reed. 2003. Corynebacterium
nigricans sp. nov.: Proposed Name for a Black-Pigmented Corynebacterium species Recovered from the
Human Female Urogenital Tract. J. Clin. Microbiol. 41:4353-4358
Shukla, S., K., K. A. Bernard, M. Harney, D. N. Frank, and K. D. Reed. 2004. Corynebacterium
nigricans sp. nov.- publication as valid bacterial name, validation list 95. Int J Syst Evol Microbiol 2004
54: 1-2.
Simons, F.E.R, Shikishima, Y., van Nest, G., Eiden, J. and HayGlass, K.T. Selective redirection of
immunoregulatory responses in ragweed-allergic humans using Amb a1 immunostimulatory sequence
conjugates. J. Allergy Clin. Immunol. (2004 Jun;113(6):1144-51.
Simor AE, Ofner-Agostini M, Bryce E, Green K, McGeer A, Mulvey MR, Paton S, the CANADIAN
HOSPITAL EPIDEMIOLOGY COMMITTEE (MULVEY M, EMBIL J AND EMBREE JE, MEMBERS) and the
Canadian Nosocomial Infection Surveillance Program, Health Canada.
The evolution of methicillinresistant Staphylococcus aureus in Canadian hospital: 5 years of national surveillance, 1995-1999. Can
Med Assoc J;165: 21-26, 2001.
Simor AE, Ofner-Agostini M, Bryce E, McGeer A, Paton S, Mulvey MR, the CANADIAN HOSPITAL
EPIDEMIOLOGY COMMITTEE (MULVEY M, EMBIL J AND EMBREE JE, MEMBERS) and the Canadian
Nosocomial Infection Surveillance Program, Health Canada. Laboratory characterization of methicillinresistant Staphylococcus aureus in Canadian hospital: Results of 5 years of national surveillance, 19951999. J Infect Dis; 186: 652- 660, 2002.
Skowronski, D.M., Lu, H., Warrington, R., Hegele R., Serres, G. D., Hayglass, K., Stark, D., White, R.,
MacNabb, J., Li, Y., Madison, H., and Brunham, R. (2003). Does antigen specific cytokine response
correlate with the experience of oculo-respiratory syndrome following influenza vaccine? J. Infect. Dis.
187: 495-499.
Smith HJ, Nichol K, Hoban DJ, Zhanel GG. Stretching the mutant prevention concentration (MPC)
beyond its limits. Journal of Antimicrobial Chemotherapy, 2003;51(6):1323-1325.
Smith HJ, Nichol KA, Hoban DJ, Zhanel GG. Dual activity of fluoroquinolones against Streptococcus
pneumoniae: The facts behind the claims. Journal of Antimicrobial Chemotherapy, 2003;51(2):63-67.
Smith HJ, Noreddin A, Siemens CG, Schurek KN, Greisman J, Hoban CJ, Hoban DJ and Zhanel GG.
Designing Fluoroquinolone Breakpoints for Streptococcus pneumoniae Using Genetics Instead of
Pharmacokinetics/Pharmacodynamics. Antimicrobial Agents and Chemotherapy 2004:48:3630-3635.
Smith HJ, Walters M, Nichol KA, Zhanel GG and Hoban DJ. Mutant prevention concentrations of single-step
fluoroquinolone-resistant mutants of Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy
2004;48:3954-3958.
Smith J, Bosetti C, Muñoz N, Herrero R, Bosch FX, Eluf-Neto J, Meijer CJLM, van den Brule AJC,
Franceschi S, Peeling RW for the IARC Multi-centric Cervical Cancer Study Group. Chlamydia
trachomatis and invasive cervical cancer: a pooled analysis of the IARC multicentric case-control study.
Int J Cancer 111: 431-439, 2004.
Smith J.S., Muñoz N., Herrero R., Eluf-Neto J., Ngelangel C., Franceschi S., Bosch F.X., Walboomers
J.M.M., Peeling R.W. Evidence for Chlamydia trachomatis as a Human Papillomavirus Cofactor in the
Etiology of Invasive Cervical Cancer in Brazil and the Philippines. J Infect Dis 185:324-31, 2002.
Solomon AW, Foster A, Peeling RW, Mabey DCW. Diagnosis and assessment of trachoma. Clin.
Microbiol. Reviews 17: 982-1011, 2004.
Solomon AW, Holland MJ, Alexander NDE, Massae PA, Aguirre A, Natividad-Sancho A, Molina S, Safari S,
Shao JF, Peeling RW, West SK, Bailey RL, Foster A, Mabey DCW. High coverage mass treatment with
single-dose azithromycin interrupts transmission of trachoma. N Engl J Med. 2004.
Solomon AW, Holland MJ, Burton MJ, West SK, Alexander NDE, Aguirre A, Massae PA, Mkocha H, Munoz
B, Johnson GJ, Peeling RW, Bailey RL, Foster A, Mabey DCW. Strategies for the control of trachoma:
observational study with quantitative PCR. Lancet 362:198-204, 2003.
Stanberry LS, Spruance SL, Cunningham AL, Bernstein DI, Mindel A, Sacks S, Tyring S, Aoki FY, Slaoui
M, Denis M, Vandepapeliere P, Dubin G for the GlaxoSmithKline Herpes Vaccine Efficacy Study Group (P.
Orr, member). Glycoprotein D vaccine to prevent genital herpes disease. N Engl J Med 2002; 347:16521661.
Stenmark, P., Högbom, M., Roshick, C., McClarty, G. and Nordlund, P. 2004 Crystals of the
ribonucleotide reductase R2 protein from Chlamydia trachomatis obtained by heavy-atom co
crystallization. Acta Crystallogr D Biol Crystallogr. 60:376-8.
Strijack C, Harding GK, Ariano R, Zelenitsky SA. A peritoneal fluid titer test for peritoneal dialysisrelated peritonitis. Antimicrob Agents Chemother. 2004;48(5):1719-1726.
Stroeher U, West E, Bugany H, Klenk HD, Schnittler HJ, Feldmann H (2001). Infection and activation of
monocytes by filoviruses. J. Virol. 75: 11025-11033.
Ströher U, CiCaro A, Li Y, Strong JE, Aoki, FY, Plummer FA, Jones SM, Feldmann H. SARS-related
coronavirus is inhibited by interferon-Alpha. J Inf Dis 2004; 189:1164-1167.
Su H, McClarty G, Dong F, Hatch G, Pan Z, Zhong G. 2003 Activation of Raf/MEK/ERK/cPLA2 signaling
pathway is essential for chlamydial acquisition of host glycerophospholipids. J. Biol. Chem. 279:9409-16.
Swanson, M.I., Y.-M. She, W. Ens, E.G. Brown, and K.M. Coombs. (2002). Mammalian reovirus core
protein mu2 initiates at the first start codon and is acetylated. Rapid Comm. Mass Spectrom. 16:23172324.
Takada A, Feldmann H, Ksiazek T, Kawaoka Y (2003). Antibody-dependent enhancement of Ebol avirus
infection. J. Virol. 77: 7539-7544.
Takada A, Feldmann H, Stroeher U, Bray M, Watanabe S, Ito H, McGregor M, Kawaoka Y. (2003).
Identification of protective epitopes on Evbola virus glycorptoein at the single amino acid level by using
recombinant vesicular stomatitis viruses. J. Virol. 77: 1069-1074.
Takada A, Fujioka K, Tsuiji M, Morikawa A, Higashi N, Ebihara H, Kobassa D, Feldmann H, Irimura T,
Kawaoka Y. (2004). Human macrophage C-type lectin specific for galactose and N-acetylgalactosamine
promotes filovirus entry. J. Virol. 78: 2943-2947.
Talan DA, Klimerg IW, Nicolle LE, Song J, Kowalsky SF, Church DA. Once-daily extended-release
ciprofloxacin for the treatment of complicated urinary tract infections and acute uncomplicated
pyelonephritis. Jour Urol 2004; 171: 734-739.
Tang P., Louie M., Richardson R., Smieja M., Simor A.E., Jamieson, F., Fearon, M., Poutanen, S.M.,
Mazzulli, T., Tellier, R., Mahony, J., Loeb, M., Petrich, A., Chernesky, M., McGeer, A., Low, D.E., Phillips,
E., Jones S, Bastien N, Li, Y, Dick D, Fernando L, Booth T.F, Henry, B., Rachlis, A.R., Matukas, L.M.,
Rose, D.B., Lovinsky, R., Walmsley, S., Gold, W.L., Krajden, S., and the Ontario Laboratory Working
Group for the rapid Diagnosis of Emerging Infections. (2004). Interpretation of diagnostic laboratory tests
for severe acute respiratory syndrome: the Toronto experience. CMAJ. 170: 47-54.
Taylor G, Gravel D, Johnston L, Embil JM, Holton D, Payton S, the Canadian Nosocomial Infection
Surveillance Program, and the Canadian Hospital Epidemiology Committee. Incidence of Bloodstream
Infection in Multicentre Inception Cohorts of Hemodialysis Patients. Am J Infect Control 2004; 32: 155-160.
Taylor GD, Gravel D, Johnston L, Embil J, Holton D, Paton S, the CANADIAN HOSPITAL EPIDEMIOLOGY
COMMITTEE (MULVEY M, EMBIL J, AND EMBREE JE, MEMBERS) and the Canadian Nosocomial
Infection Surveillance Program, Health Canada. Prospective surveillance for primary blood stream
infection occurring in Canadian hemodialysis units. Infect Control Hosp Epidemiol; 23(12): 716-20, 2002.
Taylor, D. E., L.-K. Ng, I. Martin, M. Rooker, M. Keelan, N.T. Perna, N.T.V. Burland, and F. R. Blattner.
2002. Genomic variability of O islands encoding tellurite resistance in enterohemorrhagic Escherichia coli
O157:H7 isolates. J. Bacteriol. 184:4690-4698.
The Canadian Tuberculosis Laboratories Technical Network, T. V. Burdz, J. Wolfe, A. Kabani. 2004.
Evolution of a quality assurance program in Canadian Mycobacteriology Laboratories: 3 years of
proficiency testing data. Am. J. Clin. Pathology. 121:566-573.
Tipples GA, D Safronetz and M Gray. A real-time PCR assay for the detection of varicella-zoster virus
DNA and differentiation of vaccine, wild-type and control strains. J Virol Meth 113:113-6 (2003).
Tipples GA, GM Stephens, C Sherlock, M Bowler, B Hoy, D Cook and C Grose. A new variant of varicellazoster virus. Emerg Infect Dis 8:1504-5 (2002).
Tipples GA, M Garbutt, M Gray, PA Rota, and the Canadian Measles Surveillance Program. Genotyping of
measles virus in Canada: 1979 to 2002. J Infect Dis 189 (Suppl. 1):S171-S176 (2004).
Tipples GA, R Hamkar T Mohktari-Azad, M Gray, G Parkyn and S Ratnam. Evaluation of rubella IgM
serology assays. J Clin Virol 30:233-238 (2004).
Tipples GA, R Hamkar, T Mohktari-Azad, M Gray, G Parkyn, C Head and S Ratnam. Assessment of
measles IgM serology assays. J Clin Microbiol 41:4790-2 (2003).
Trivedi HN, Plummer FA, Anzala AO, Njagi E, Bwayo JJ, Ngugi EN, Embree JE, Hayglass KT. Resistance
to HIV-1 infection among African sex workers is associated with global hyporesponsiveness in interleukin 4
production. FASEB J 15: 1795-1797, 2001.
Tsang, R. S. W., G. Figueroa, L. Bryden, and L.-K. Ng. 2001. Flagella as a potential marker for
Campylobacter jejuni strains associated with Guillain-Barré Syndrome. J. Clin. Microbiol. 39(2):762-764.
Tsang, R. S., D. K. S. Law, C.-M. Tsai, L.-K. Ng. 2001. Detection of the lst gene in different serogroups
and LOS immunotypes of Neisseria meningitidis. FEMS Microbiol. Lett.199:203-206.
Turenne C. Y., L. Thibert, K. Williams, T. V. Burdz, V. J. Cook, J. Wolfe and A. Kabani. 2004.
Mycobacterium saskatchewense sp. nov., a new slow-growing scotochromogenic species related to
Mycobacterium interjectum and Accuprobe positive for M. avium complex from human clinical isolates. Int
J Syst Evol Microbiol. 54(3):659-67.
Turenne C. Y., V. J. Cook, T. V. Burdz, R. J. Pauls, L. Thibert, J. Wolfe and A. Kabani. Mycobacterium
parascrofulaceum sp. nov., a novel slowly growing clinical isolate related to Mycobacterium simiae. Int. J.
Syst. Evol. Microbiol. Published online 4 June 2004. DOI 10.1099/ijs.0.02940-0
Turenne, C. Y., L. Tschetter, J. Wolfe, and A. M. Kabani. 2001. The Necessity of Quality Controlled 16S
rRNA Gene Sequence Databases: Identifying Non-Tuberculous Mycobacterium Species. J. Clin. Microbiol.
39(10): 3637-3648.
Turenne, C. Y., P. Chedore, J. Wolfe, F. Jamieson, G. Broukhanski, K. May, and A. Kabani. 2002.
Mycobacterium lacus, sp. nov., a novel slowly growing, non-chromogenic clinical isolate. Int. J. Syst. Evol.
Microbiol. 52: 2135-2140.
Turenne, C., P. Chedore, J. Wolfe, F. Jamieson, K. May, A. Kabani. 2002. Phenotypic and Molecular
Characterization of Clinical Isolates of Mycobacterium elephantis from Human Specimens. .J. Clin.
Microbiol 40(4):1230-1236.
Turenne, C., Suchak, A.A., Wolfe, J.N., Kabani, A., Nicolle, L.E. Soft tissue infection caused by a novel
pigmented rapidly growing Mycobacterium species. Jour Clin Microbiol 2003; 41: 2779-2782.
Turnak MR, Bandak SI, Bouchillon SK, Allen BS, Hoban DJ. Antimicrobial susceptibilities of clinical
isolates of Haemophilus influenzae and Moraxella catarrhalis collected during 1999-2000 from 13
countries. Clinical Microbiology and Infection, 2001;7(12):671-677.
Tyring S, Engst R, Corriveau C, Robillard N, Trottier S, Van Slycken S, Cran RA, Locke LA, Saltzman R,
Palestine AG and the Collaborative Famciclovir Ophthalmic Zoster Research Group (FY Aoki and P Orr,
members). Famciclovir for ophthalmic zoster: a randomised acyclovir-controlled study. Br J Ophthalmol
2001; 85:576-581.
Van Caeseele P, Macaulay A, Orr P, Aoki FY, Martin B. Rapid pharmacotherapeutic intervention for an
influenza A outbreak in the Canadian Arctic: lessons from the Sanikiluaq experience. Int J Circumpol
Health 2001; 60:640-648.
Van Caeseele, P., S. Giercke, J. L. Wylie, S. Amin, M. Ofner-Agostini, D. Boyd, M. Mulvey. 2001.
Identification of the first Enterococcus faecalis harbouring vanE in Canada. Can. Commun. Dis. Report.
27:101-104.
Van Damme P, Leroux-Roels G, Law B, Diaz-Mitoma F, Desombere I, Van Herck K, Collard F, Tornieporth
N. Long term persistence (5-6 years) of antibodies induced by vaccination and safety follow-up, with the
first combined vaccine against hepatitis A and B in children and adults. J Med Virology 2001; 65:6-13.
Van de Werf MJ et al (Nagelkerke NJD). Quantification of clinical morbidity associated with schistosome
infection in sub-Saharan Africa. Acta Trop. 2003 May;86(2-3):125-39.
Van den Hoogen P et al (Nagelkerke NJD). Relation between blood pressure and mortality: is there a
threshold? Eur Heart J. 2001 Nov;22(22):2132-3.
Van der Werf MJ et al (Nagelkerke NJD). Associating community prevalence of Schistosoma mansoni
infection with prevalence of signs and symptoms. Acta Trop. 2002 May;82(2):127-37.
Van Tiel ED et al (Nagelkerke NJD). Quitting smoking may restore hematological charateristics within
five years. Annals Epid. 2002; 12:378-388.
Vera-Cabrera L, Hernandez-Vera MA, Welsh O, Johnson WM, Castro-Garza J. Phospholipase Region of
Mycobacterium tuberculosis is a Preferential Locus for IS6110 Transposition. J Clin Microbiol. 2001
Oct;39(10):3499-504.
Vickerman P, Watts C, Alary M, Mabey D, Peeling RW. Sensitivity requirements for the point of care
diagnosis of Chlamydia trachomatis and Neisseria gonorrhoeae. Sex Transm Inf. 79:363-7, 2003.
Voogt N et al (Nagelkerke NJD). Differences between national reference laboratories of the European
community in their ability to serotype Salmonella species. Eur J Clin Microbiol Infect Dis. 2002
Mar;21(3):204-8.
Walters KA, GA Tipples, MI Allen, LD Condreay, WR Addison and L Tyrrell. Generation of stable cell lines
expressing lamivudine-resistant hepatitis B virus for antiviral-compound screening. Antimicrob Agents and
Chemother 47:1936-42 (2003).
Wang G, Clark CG, Liu C, Pucknell C, Munro CK, Kruk TMAC, Caldeira R, Woodward DL, Rodgers FG.
2003. Detection and characterization of the hemolysin genes in Aeromonas hydrophila and Aeromonas
sobria by multiplex PCR. J Clin Microbiol 41:1048-1054.
Wang G, Clark CG, Rodgers FG. 2002. Detection in Escherichia coli of the genes encoding the major
virulence factors, the genes defining the O157:H7 serotype, and components of the type 2 Shiga toxin
family by multiplex PCR. J Clin Microbiol 40:3613-3619.
Wang G, Clark CG, Taylor TM, Pucknell C, Barton C, Price L, Woodward DL, Rodgers FG. 2002. Colony
multiplex PCR assay for identification and differentiation of Campylobacter jejuni, C. coli, C. lari, C.
upsaliensis, and C. fetus subsp. fetus. J Clin Microbiol 40:4744-4747.
Wang QQ, Peeling RW, Mabey D, Yang P, Zhong MY, Wang GJ, Tan ML, Jian DM. Validation of
Syndromic Algorithm for the Management of Genital Ulcer Diseases in China. Int J STD & AIDS 13:46974, 2002.
Watanabe S, Watanabe T, Noda T, Takada A, Feldmann H, Jasenosky LD, Kawaoka Y (2004).
Production of novel Ebola virus-like particles from cDNAs: an alternative to Ebola virus generation by
reverse genetics. J. Virol. 78: 999-1005.
Weingartl H, Czub M, Czub S, Neufeld J, Marszal P, Gren J, Smith G, Jones S, Proulx R, Deschambault
Y, Grudeski E, Andonov A, He R, Li, Y, Copps J, Grolla A, Dick D, Berry J, Ganske S, Manning L, Cao J
[2004] Immunization with modified vaccinia virus Ankara-based recombinant vaccine against sever acute
respiratory syndrome is associated with enhanced hepatitis in ferrets. J Virol 78, No.22.
Weingartl HM (2002) Porcine circovirus structure and replication: a minireview. Agriculture 1: 11 – 14.
Weingartl HM, Copps J, Drebot MA, Marszal P, Smith G, Gren J, Andonova M, Pasick J, Kitching P,
Czub M. (2004). Susceptibility of pigs and chickens to severe acute respiratory syndrome coronavirus.
Emerg Infect Dis 10(2):179-84.
Weingartl HM, Drebot MA, Hubalek Z, Halouzka J, Andonova M, Dibernardo A, Cottam-Birt C, Larence
J, Marszal P. (2003) Comparison of assays for detection of West Nile virus antibodies in chicken sera.
Can J Vet Res 67:128-132.
Weingartl HM, Neufeld JL, Copps J, Marszal P [2004] Experimental West Nile virus infection in blue jays
(Cyanocitta cristata) and crows (Corvus brachyrhynchos). Vet Pathol 41: 362 – 370.
Weingartl HM, Riva, J., Kumthekar, P.(2003) Molecular Characterization of Avian Paramyxovirus 1
Isolates from Cormorants in Canada from Year 1995 - 2000. J.Clin.Microb., 41: 1280 - 1284
Weingartl HM, Sabara M, Pasick J, van Moorlehem E, Babiuk L (2002) Continuous porcine cell lines
developed from alveolar macrophages. Partial characterization and virus susceptibility. J Virol Meth 104:
203 – 216
Weingartl, H, Czub M, Czub S, Neufeld J, Marszal P, Gren J, Smith G, Jones S, Proulx R, Deschambault
Y, Grudeski E, Andonov A, He R, Li Y, Copps J, Grolla A, Dick D, Berry J, Ganske S, Manning L, Cao J.
(2004) Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe
acute respiratory syndrome is associated with enhanced hepatitis in ferrets. J Virol 78:12672-6.
Welliver R, Monto AS, Carewica O, Schatteman E, Hassman M, Hedrick J, Jackson HC, Huson L, Ward P,
Oxford JS for the Oseltamivir Post Exposure Prophylaxis Investigator Group (Aoki FY, member).
Effectiveness of oseltamivir in preventing influenza in household contact. A randomised controlled trial. J
Amer Med Assoc 2001; 285:748-754.
Wichmann D, Gröne HJ, Frese M, Pavlovic J, Haller O, Klenk HD, Feldmann H. (2002). Hantaan virus
infection causes an acute, lethal encephalitis in adult immunocompetent laboratory mice. J. Virol., 76:
8890-8899.
Wichmann D, Slenczka W, Alter P, Boehm S, Feldmann H (2001). Hemorrhagic fever with renal
syndrome: diagnostic problems with a known disease. J. Clin. Microbiol.39: 3414-3416.
Wiseman M, Orr P, Macdonald S et al. Actinic Prurigo: Clinical Features and HLA Associations in a Canadian
Inuit Population. J Am Acad Dermatol 2001;44:952-6.
Wolf K, Fischer E, Mead D, Zhong GM, Peeling R, Whitmore B, Caldwell HD. The Chlamydia
pneumoniae MOMP is a surface-exposed antigen that elicits antibodies primarily directed against
conformation-dependent determinants. Infect Immun 69:3082-91, 2001.
Wong SJ, Boyle RH, Demarest VL, Woodmansee AN, Kramer LD, Li H, Drebot M, Koski RA, Fikrig E,
Martin DA, Shi PY. (2003) Immunoassay targeting nonstructural protein 5 to differentiate West Nile
virus infection from dengue and St. Louis encephalitis virus infections and from flavivirus vaccination. J
Clin Microbiol. 41:4217-4223
Wood, H., C., Roshick, C. McClarty,G. 2004 Interferon gamma resistance of Chlamydia psittaci GPIC
results from tryptophan recycling. Mol Micro 52:903-916.
Wood, H., Fehlner-Gardiner, C., Berry, J., Fischer, E., Graham, B., Hackstadt, T. Roshick, C.McClarty,G.
2003. Regulation of tryptophan synthase gene expression in Chlamydia trachomatis Mol. Micro. 49:
1347-1359.
Wood, M, Dawood, M, Nowicki, D, Matusko, P, Hammond GW. HIV Strain and Drug Resistance
Surveillance. CCDR, June 2002.
Woodward DL, Clark CG, Caldeira RA, Ahmed R, Rodgers FG. 2002. Verotoxigenic Escherichia coli
(VTEC): A Major Public Health Threat in Canada . Can J Infect Dis 13:321-330.
Wylie, J. L. and A. M. Jolly. 2001. Patterns of chlamydia and gonorrhea infection in sexual networks in
Manitoba, Canada. Sex. Trans. Dis. 28:14-24. Published with accompanying editorial by Klovdahl, A. S.
2001. Networks and pathogens. Sex. Transm. Dis. 28:25-28.
Yang X, S. Wang, Y. Fan, X. Han, J. Yang and L. Chen. Mycobacterial infection inhibits established
allergy responses by modifying cytokine production and adhesion molecule expression. Immunology
105:336-343, 2002
Yang X. Cytokine responses in chlamydial diseases (invited review). Curr Pharm Design, 9:67-73, 2003.
Yang X. Distinct functions of Th1 and Th2 type responses in delayed type hypersensitivity: Defence
against chlamydial infection (invited review). Mic. Res. Tec, 53:273-277. 2001.
Yao X-J, J. Lemay, N. Rougeau, M. Clément, S. Kurtz, P. Belhumeur, and E.A. Cohen. 2002. Genetic
Selection of peptide inhibitors of human immunodeficiency virus type 1 (HIV-1) Vpr. J. Biol Chem. 277:
48816-48826.
Yuan, X., Gubbins, M., and J.D. Berry. (2004). Determination of functional kappa light chain cDNAs from
aberrant-chain-positive p3-X63-Ag8.653 derived murine hybridomas. J. Immunol. Methods 294, 199-207.
Zaman Alli, Ravinder K. Sardana, Anton Andonov, Laurian S. Robert, Johann P. Schernthaner, Béatrice
Pierre, Suzanne L. Porter, Anil K. Dudani, Peter R. Ganz, Eilleen S. Tackaberry, and Illimar Altosaar.
(2002) Pharming vaccines for hepatitis and cytomegalovirus: Towards the development of multivalent
and subunit vaccines for oral delivery of antigens. Phytochemistry Reviews, 1, 55-66.
Zanden AGM et al (Nagelkerke NJD. Improvement of differentiation and interpretability of spoligotyping
for Mycobacterium tuberculosis Complex by the introduction of new spacer oligonucleotides. J Clin
Microbiol. 2002 Dec;40(12):4628-39.
Zelenitsky S, Franczuk C, Fine A, Ariano R, Harding G. Antibiotic tolerance of peritoneal bacterial
isolates in dialysis fluids. J Antimicrob Chemother. 2002:49(5);863 – 866.
Zelenitsky S, Iacovides H, Harding GK, Ariano RE. Effect of antibiotic sequence on combination
regimens against Pseudomonas aeruginosa in a multiple-dose, in-vitro infection model. Diagn Microbiol
Infect Dis. 2004;49:67-70.
Zelenitsky SA, Ariano RE, Harding GKM, Silverman RE. Antibiotic pharmacodynamics in surgical
prophylaxis: An association between intraoperative antibiotic concentrations and efficacy. Antimicrob
Agents Chemother. 2002:46(9);3026-3030.
Zelenitsky SA, Ariano RE, Iacovides H, Sun S, Harding GK. AUC0-t/MIC is a continuous index of
fluoroquinolone exposure and predictive of antibacterial response for Streptococcus pneumoniae in an in
vitro infection model. J Antimicrob Chemother. 2003 Apr;51(4):905-11.
Zelenitsky SA, Harding GK, Sun S, Ubhi K, Ariano RE. Treatment and outcome of Pseudomonas
aeruginosa bacteremia: an antibiotic pharmacodynamic analysis. J Antimicrob Chemother. 2003 Sep
1;52:668-674.
Zhanel GG, DeCorby M, Noreddin A, Mendoza C, Cumming A, Nichol, Wierzbowski A and Hoban DJ.
Pharmacodynamic activity of azithromycin against macrolide-susceptible and macrolide-resistant (PCR
positive mefA or ermB) Streptococcus pneumoniae simulating clinically achievable free serum and epithelial
lining fluid (ELF) and middle ear fluid (MEF) concentrations. Journal of Antimicrobial Chemotherapy 2003;
52(1):83-88.
Zhanel GG, Dueck M, Hoban DJ, Vercaigne LM, Embil JM, Gin AS, Karlowsky JA. Review of Macrolides
and Ketolides: Focus on Respiratory Tract Infections. Drugs 2001; 61: 443-98.
Zhanel GG, Embil JM. Tendinopathy in Fluoroquinolones: What is the Risk? J Resp Dis 2004; 25: 227.
Zhanel GG, Ennis K, Vercaigne L, Walkty A, Gin AS, Embil JM, Hoban DJ. A Critical Review of the
Flouroquinalones: Focus on Respiratory Infections. Drugs 2002; 62: 13-59.
Zhanel GG, Hisanaga T, Nichol K, Wierzbowski A, Hoban DJ. Ketolides: an emerging treatment for
macrolide-resistant respiratory infections, focusing on S. pneumoniae. Expert Opinion Emerging Drugs,
2003;8:297-321.
Zhanel GG, Hoban DJ, Chan CK. Resistance to levofloxacin and failure of pneumococcal pneumonia.
New England Journal of Medicine, 2002;347-366.
Zhanel GG, Hoban DJ. Ketolides in the treatment of respiratory infections. Expert Opinion
Pharmacotherapy, 2002;3(3):277-297.
Zhanel GG, Homenuik K, Nichol K, Norredin A, Vercaigne L, Embil J, Gin A, Karlowski JA, Hoban DJ. The
Glycylcyclines: A Comparative Review with the Tetracyclines. Drugs 2004; 64: 63-88.
Zhanel GG, Karlowsky JA, Hoban DJ. Activity of nitrofurantoin against vancomycin resistant
Enterococci. Antimicrobial Agents and Chemotherapy, 2001;45:324-326.
Zhanel GG, Laing NM, Nichol KA, Palatnick LP, Noreddin A, Hisanaga T, Johnson JL, the NAVRESS
Group, Hoban DJ. Antibiotic activity against urinary tract infection (UTI) isolates of vancomycinresistant enterococci (VRE): results from the 2002 North American Vancomycin Resistant Enterococci
Susceptibility Study (NAVRESS). Journal of Antimicrobial Chemotherapy, 2003;52:382-388.
Zhanel GG, Palatnick L, Nichol KA, Bellyou T, Low DE, The CROSS Study Group, Hoban DJ. Five year
incidence of antimicrobial resistance in respiratory tract isolates of Streptococcus pneumoniae: results of
the Canadian Respiratory Organism Susceptibility Study (CROSS), 1997-2002. Antimicrobial Agents and
Chemotherapy, 2003;47:1867-1874.
Zhanel GG, Palatnick L, Nichol KA, Low DE, The CROSS Study Group, Hoban DJ. Five year incidence of
antimicrobial resistance in respiratory tract isolates of Haemophilus influenzae and Moraxella catarrhalis:
Results of the Canadian Respiratory Organism Susceptibility Study (CROSS) 1997-2002. Antimicrobial
Agents and Chemotherapy, 2003;47:1875-1881.
Zhanel GG, Roberts D, Walkty A, Laing N, Nichol K, Smith H, Noreddin A, Bellyou T, Hoban DJ.
Pharmacodynamic activity of fluoroquinolones against Ciprofloxacin-resistant Streptococcus pneumoniae.
Journal of Antimicrobial Chemotherapy, 2002;49:807-812.
Zhanel GG, Saunders D, Hoban DJ and Karlowsky JA. Influence of human serum on the
pharmacodynamics of antifungals. Antimicrobial Agents and Chemotherapy 2001;45:2018-2022.
Zhanel GG, Schroeder C, Vercaigne L, Gin AS, Embil JM, Hoban DJ. A Critical Review of Oxazolidinone:
An Alternative or Replacement for Glycopeptides and Streptogramins? Can J Infect Dis 2001; 12: 379-390.
Zhanel GG, Walkty A, Nichol K, Smith H, Hoban DJ. Molecular characterization of fluoroquinolone
resistant Streptococcus pneumoniae clinical isolates obtained from across Canada. Diagnostic
Microbiology and Infectious Disease, 2003;45:63-67.
Zhanel GG, Walters M, Laing N, Hoban DJ. In vitro pharmacodynamic modelling simulating free serum
concentrations of fluoroquinolones against multidrug-resistant Streptococcus pneumoniae. Journal of
Antimicrobial Chemotherapy, 2001;47(4):435-440.
Zhanel GG, Walters M, Noreddin A, Vercaigne LM, Wierzbowski A, Embil JM, Gin AS, Douthwaite S, Hoban
DJ. The Ketolides: A Critical Review. Drugs 2002; 62: 1771-1804.
Zhanel GG, Wierzbowski AK, Hisanaga T, Hoban DJ. The use of ketolides in treatment of upper
respiratory tract infections. Current Infectious Diseases Reports, 2004;6:191-199.
Zhu, P., M. J. Klutch, M. C. Bash, R. S. W. Tsang, L.-K. Ng and C.-M. Tsai. 2002. Genetic Diversity of
three lgt loci for biosynthesis of lipooligosaccharide (LOS) in Neisseria species. Microbiol. 148:1833-1844.
Zhujun Ao, X-J Yao* and E.A. Cohen* 2004. Assessment of the Role of the Central DNA Flap in Human
Immunodeficiency Virus Type 1 Replication using a Single-Cycle Replication System. J. Virol. 78:31703177 (* corresponding authors)
Zoutman D, Ford BD, Bryce E, Gourdeau M, Hebert C, Henderson E, Paton S, and the CANADIAN
HOSPITAL EPIDEMIOLOGY COMMITTEE (MULVEY M, EMBIL J AND EMBREE JE, MEMBERS). The state
of infection surveillance and control in Canadian acute care hospitals. Am J Infect Control ; 31:266-273,
2003.
Zoutman D, Ford BD, Bryce E, Gourdeau M, Hebert G, Henderson E, Paton S, and the CANADIAN
HOSPITAL EPIDEMIOLOGY COMMITTEE (MULVEY, M, EMBIL J AND EMBREE JE, MEMBERS). The
state of infection surveillance and control in Canadian acute care hospitals. Can J Infect Control; 18: 144152, 2003.